Archive BacDiveID:10.13145/bacdive12760.20230509.8.1

Strain identifier

BacDive ID: 12760

Type strain:

Species: Pseudomonas paraeruginosa

Strain Designation: PA7, R. Hugh 813

Strain history: CIP <- 1983, ATCC <- C.P. Hegarty, strain: R. Hugh 813

NCBI tax ID(s): 287 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.

General

@ref: 572

BacDive-ID: 12760

DSM-Number: 1128

keywords: genome sequence, 16S sequence, Bacteria, obligate aerobe, mesophilic, motile, antibiotic resistance, human pathogen

description: Pseudomonas paraeruginosa PA7 is an obligate aerobe, mesophilic, motile human pathogen that has multiple antibiotic resistances and was isolated from outer ear infection.

NCBI tax id

NCBI tax id: 287
Matching level: species

strain history

@ref	history
572	<- ATCC; ATCC 9027 <- C.P. Hegarty;
67770	IAM 13074 <-- NCIMB 8626 <-- ATCC 9027 <-- C. P. Hegarty.
116095	CIP <- 1983, ATCC <- C.P. Hegarty, strain: R. Hugh 813

doi: 10.13145/bacdive12760.20230509.8.1

Name and taxonomic classification

LPSN

@ref: 20215
description: domain/bacteria
keyword: phylum/pseudomonadota
domain: Bacteria
phylum: Pseudomonadota
class: Gammaproteobacteria
order: Pseudomonadales
family: Pseudomonadaceae
genus: Pseudomonas
species: Pseudomonas paraeruginosa
full scientific name: Pseudomonas paraeruginosa Rudra et al. 2022

@ref: 572

domain: Bacteria

phylum: Proteobacteria

class: Gammaproteobacteria

order: Pseudomonadales

family: Pseudomonadaceae

genus: Pseudomonas

species: Pseudomonas aeruginosa

full scientific name: Pseudomonas aeruginosa (Schroeter 1872) Migula 1900

strain designation: PA7, R. Hugh 813

type strain: no

Morphology

cell morphology

@ref	motility	confidence	gram stain	cell shape
69480	yes	98.925
69480		99.986	negative
116095	yes		negative	rod-shaped

Culture and growth conditions

culture medium

@ref	name	growth	link	composition
572	COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)	yes	https://mediadive.dsmz.de/medium/693	Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
572	NUTRIENT AGAR (DSMZ Medium 1)	yes	https://mediadive.dsmz.de/medium/1	Name: NUTRIENT AGAR (DSMZ Medium 1) Composition: Agar 15.0 g/l Peptone 5.0 g/l Meat extract 3.0 g/l Distilled water
41819	MEDIUM 72- for trypto casein soja agar	yes		Distilled water make up to (1000.000 ml);Trypto casein soy agar (40.000 g)
572	TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)	yes	https://mediadive.dsmz.de/medium/92	Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water
116095	CIP Medium 72	yes	https://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=72
116095	CIP Medium 3	yes	https://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=3

culture temp

@ref	growth	type	temperature	range
572	positive	growth	37	mesophilic
41819	positive	growth	30	mesophilic
67770	positive	growth	30	mesophilic
116095	positive	growth	10-41
116095	no	growth	5	psychrophilic

Physiology and metabolism

oxygen tolerance

@ref: 116095
oxygen tolerance: obligate aerobe

antibiogram

@ref	medium	incubation temperature	incubation time	oxygen condition	ticarcillin	mezlocillin	cefotaxime	aztreonam	imipenem	tetracycline	chloramphenicol	gentamycin	amikacin	erythromycin	ofloxacin	norfloxacin	colistin	pipemidic acid	polymyxin b	kanamycin	neomycin	doxycycline	ceftriaxone	fosfomycin	moxifloxacin	piperacillin/tazobactam
572	Mueller-Hinton Agar	37	1	aerob	28	20	24	28-30	28	12	10	20	24	8	24	30	14	16	16	12	18	10	24	36	24	28
572	Mueller-Hinton Agar	37		aerob	28	20	22-24	30	28	12-14	12	24-26	28	8	26	30-32	16	18	18	12-14	18	10	24	36	24	28
572	Mueller-Hinton Agar				28-30	20	24	30	26-28	12	12	22	26	10	24	32	14	16-18	16	12	18	10	24	36	24	26
572	Mueller-Hinton Agar				28	20-22	24	30	28	12	16-18	20-22	24-26	18	24-26	30	14	16-18	14-16	12	16-18	8	24	36-38	24	26-28
572	Mueller-Hinton Agar				28	20	22	30	28-30	12	12	22	24-26	6	24	32	14-16	18	14-16	26	18	8	24	36-38	24	28
572	Mueller-Hinton Agar	37	1	aerob	28-30	22	26	30	28	10	12	22	26	10	24	30	12-14	16	16	14	18	6	26	36	24	28
572	Mueller-Hinton Agar	37		aerob	26-28	20	22	28	26	8-10	10	18-20	26	6	24	30	14	14	16	10-12	18	8	20	32-34	20-22	26-28
572	Mueller-Hinton Agar	37		aerob	26-28	20	22	28	26	8-10	10	18-20	26	6	24	30	14	14	16	10-12	18	8	20	32-34	20-22	26-28
572	Mueller Hinton	37		aerob	26-28	18	22-24	28	28	10	14	20	24	0	22	30	14	14	16	10	18	6	24	34	22	26

spore formation

@ref	spore formation	confidence
69481	no	100
69480	no	99.979

compound production

@ref: 572
compound: rhamnolipid

metabolite utilization

@ref	Chebi-ID	metabolite	utilization activity	kind of utilization tested
68369	25115	malate	+	assimilation
68369	17128	adipate	+	assimilation
68369	27689	decanoate	+	assimilation
68369	24265	gluconate	+	assimilation
68369	17306	maltose	-	assimilation
68369	59640	N-acetylglucosamine	+	assimilation
68369	16899	D-mannitol	+	assimilation
68369	16024	D-mannose	-	assimilation
68369	30849	L-arabinose	-	assimilation
68369	17634	D-glucose	+	assimilation
68369	5291	gelatin	+	hydrolysis
68369	4853	esculin	-	hydrolysis
68369	29016	arginine	+	hydrolysis
68369	27897	tryptophan	-	energy source
116095	17632	nitrate	+	reduction
116095	16301	nitrite	+	reduction

metabolite production

@ref	Chebi-ID	metabolite	production
68369	35581	indole	no
116095	35581	indole	no

metabolite tests

@ref: 68369
Chebi-ID: 35581
metabolite: indole
indole test: -

enzymes

@ref	value	activity	ec
68369	cytochrome oxidase	+	1.9.3.1
68369	gelatinase	+
68369	beta-glucosidase	-	3.2.1.21
68369	arginine dihydrolase	+	3.5.3.6
116095	oxidase	+
116095	catalase	+	1.11.1.6
116095	urease	-	3.5.1.5
68382	alkaline phosphatase	+	3.1.3.1
68382	esterase (C 4)	+
68382	esterase lipase (C 8)	+
68382	lipase (C 14)	+
68382	leucine arylamidase	+	3.4.11.1
68382	valine arylamidase	-
68382	cystine arylamidase	-	3.4.11.3
68382	trypsin	+	3.4.21.4
68382	alpha-chymotrypsin	-	3.4.21.1
68382	acid phosphatase	+	3.1.3.2
68382	naphthol-AS-BI-phosphohydrolase	+
68382	alpha-galactosidase	-	3.2.1.22
68382	beta-galactosidase	-	3.2.1.23
68382	beta-glucuronidase	-	3.2.1.31
68382	alpha-glucosidase	-	3.2.1.20
68382	beta-glucosidase	-	3.2.1.21
68382	N-acetyl-beta-glucosaminidase	-	3.2.1.52
68382	alpha-mannosidase	-	3.2.1.24
68382	alpha-fucosidase	-	3.2.1.51

fatty acid profile

@ref	fatty acid	percentage	ECL
47686	C12:0	3.2	12
47686	C14:0	0.9	14
47686	C15:0	0.5	15
47686	C16:0	26.5	16
47686	C17:0	0.2	17
47686	C18:0	0.4	18
47686	C10:0 3OH	4.1	11.423
47686	C12:0 2OH	5.2	13.178
47686	C12:0 3OH	3.9	13.455
47686	C16:1 ω7c	15.1	15.819
47686	C17:0 CYCLO	2.7	16.888
47686	C17:1 ω8c	0.2	16.792
47686	C18:1 ω7c /12t/9t	31.9	17.824
47686	C18:1 ω9c	0.3	17.769
47686	C18:2 ω6,9c/C18:0 ANTE	0.6	17.724
47686	C19:0 CYCLO ω8c	4.4	18.9

type of FA analysis: whole cell analysis
method/protocol: CCUG

@ref	fatty acid	percentage	ECL
47686	C12:0	4.1	12
47686	C14:0	1	14
47686	C15:0	0.5	15
47686	C16:0	23.4	16
47686	C10:0 3OH	4.5	11.423
47686	C12:0 2OH	5.4	13.178
47686	C12:0 3OH	4.3	13.455
47686	C15:0 ISO 3OH	1.3	16.135
47686	C16:1 ω7c	16.6	15.819
47686	C17:0 CYCLO	1.3	16.888
47686	C18:1 ω7c /12t/9t	28.4	17.824
47686	C18:1 ω9c	0.3	17.769
47686	C18:2 ω6,9c/C18:0 ANTE	0.4	17.724
47686	C19:0 CYCLO ω8c	1.5	18.9
47686	Unidentified	3.8	16.296
47686	Unidentified	3.1	18.14

type of FA analysis: whole cell analysis
method/protocol: CCUG

API zym

@ref	Control	Alkaline phosphatase	Esterase	Esterase Lipase	Lipase	Leucine arylamidase	Valine arylamidase	Cystine arylamidase	Trypsin	alpha- Chymotrypsin	Acid phosphatase	Naphthol-AS-BI-phosphohydrolase	alpha- Galactosidase	beta- Galactosidase	beta- Glucuronidase	alpha- Glucosidase	beta- Glucosidase	N-acetyl-beta- glucosaminidase	alpha- Mannosidase	alpha- Fucosidase
116095	-	+	+	+	+	+	-	-	+	-	+	+	-	-	-	-	-	-	-	-

API 20NE

@ref	NO3	TRP	GLU_ Ferm	ADH Arg	URE	ESC	GEL	PNPG	GLU_ Assim	ARA	MNE	MAN	NAG	MAL	GNT	CAP	ADI	MLT	CIT	PAC	OX
572	-	-	+/-	+	+	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
572	-	-	-	+	+/-	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
572	+	-	-	+	+/-	-	+	+/-	+	-	-	+	+	-	+	+	+	+	+	-	+
572	+	-	-	+	-	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
47686	+	-	+	+	+	-	+	-	+	-	-	+	+	-	+	+	+	+	+	-	+
572	+	-	-	+	+	-	+	+	+	-	-	+	+	-	+	+	+	+	+	-	+

API biotype100

@ref	GLU	FRU	GAL	TRE	MNE	SBE	MEL	SAC	RAF	MTE	MAL	LAC	LTE	MbGa	MaGa	CEL	GEN	MbGu	ESC	RIB	ARA	XYL	PLE	RHA	FUC	MLZ	DARL	LARL	XLT	DUL	TAG	GLY	INO	MAN	MTL	TUR	SOR	ADO	HBG	LYX	ERY	MDG	3MDG	SAT	MUC	LTAT	DTAT	MTAT	DMLT	LMLT	CATE	TATE	TTE	CIT	GRT	GAT	2KG	5KG	TRY	NAG	GNT	PAC	PAT	pOBE	QAT	GTE	mOBE	BAT	PPAT	CMT	TGE	BET	PCE	ABT	HIN	LAT	CAP	CYT	HIS	SUC	FUM	GRE	GYT	AVT	ETN	TTN	GLN	ITA	3OBU	APT	GTT	PRO	DALA	LALA	SER	MNT	PROP	TYR	2KT
116095	+	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	+	-	-	-	-	+	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	+	+	+	-	+	-	-	+	-	-	+	+	-	+	+	+	+	-	+	-	-	-	+	+	+	+	+	+	+	-	+	+	+	+	+	+	-	-	+	+	+	+	+	+	+	+	+	+	+	+

Isolation, sampling and environmental information

isolation

@ref	sample type	geographic location	country	origin.country	continent	isolation date
572	outer ear infection
47686	Human outer ear infection
67770	Outer ear infection
116095	Human, Outer ear infection	Oregon	United States of America	USA	North America	1943

isolation source categories

Cat1	Cat2	Cat3
#Infection	#Disease
#Host Body-Site	#Organ	#Ear

Safety information

risk assessment

@ref	pathogenicity human	pathogenicity animal	biosafety level	biosafety level comment
572	yes	yes	2	Risk group (German classification)
116095			2	Risk group (French classification)

Sequence information

16S sequences

@ref: 20218
description: Pseudomonas aeruginosa strain DSM 1128 16S ribosomal RNA gene, partial sequence
accession: AF502423
length: 322
database: ena
NCBI tax ID: 287

Genome sequences

@ref	description	accession	assembly level	database	NCBI tax ID
66792	Pseudomonas paraeruginosa ATCC 9027	GCA_002601815	scaffold	ncbi	2994495
66792	Pseudomonas paraeruginosa ATCC 9027	GCA_002563335	contig	ncbi	2994495
66792	Pseudomonas paraeruginosa ATCC 9027	GCA_001294675	contig	ncbi	2994495
66792	Pseudomonas paraeruginosa ATCC 9027	GCA_001374975	contig	ncbi	2994495
66792	Pseudomonas paraeruginosa ATCC 9027	GCA_001402955	scaffold	ncbi	2994495
66792	Pseudomonas aeruginosa strain ATCC 9027	287.1969	wgs	patric	287
66792	Pseudomonas aeruginosa strain ATCC 9027	287.4560	wgs	patric	287
66792	Pseudomonas aeruginosa strain ATCC 9027	287.1867	wgs	patric	287
66792	Pseudomonas aeruginosa strain ATCC 9027	287.4563	wgs	patric	287
66792	Pseudomonas aeruginosa strain ATCC 9027	287.1942	wgs	patric	287
66792	Pseudomonas aeruginosa ATCC 9027	2675903282	draft	img	287
66792	Pseudomonas aeruginosa ATCC 9027	2645727823	draft	img	287

Genome-based predictions

predictions

trait	prediction	confidence	training_data
spore-forming	no	100	no
flagellated	yes	84.798	no
gram-positive	no	98.434	no
anaerobic	no	98.527	no
aerobic	yes	92.947	no
halophile	no	93.108	no
spore-forming	no	92.719	no
glucose-util	yes	92.772	no
thermophile	no	99.764	yes
motile	yes	90.15	no
glucose-ferment	no	89.789	no

External links

@ref: 572

culture collection no.: DSM 1128, ATCC 9027, CIP 82.118, DSM 1385, WDCM 00026, CCUG 22801, CCM 1961, IAM 10374, IFO 13275, JCM 23217, BUCSAV 278, IAM 13074, JCM 14171, NBRC 13275, NCIMB 8626, NRRL B-800, CIP 72.26, IMET 10905, NCTC 12924, CECT 111, LMG 8029, CMCC (B) 10104

straininfo link

@ref: 81969
straininfo: 3893

literature

topic	Pubmed-ID	title	authors	journal	DOI	year	mesh	topic2
Metabolism	184895	The release and characterization of some periplasm-located enzymes of Pseudomona aeruginosa.	Bhatti AR, DeVoe IW, Ingram JM	Can J Microbiol	10.1139/m76-211	1976	3',5'-Cyclic-AMP Phosphodiesterases/metabolism, Alkaline Phosphatase/metabolism, Cell-Free System, Cytoplasm/enzymology, Endonucleases/metabolism, Magnesium, Nucleotidases/metabolism, Osmotic Pressure, Phosphoric Diester Hydrolases/metabolism, Pseudomonas aeruginosa/enzymology, Ribonucleases/metabolism, Spheroplasts/enzymology, Sucrose	Enzymology
Enzymology	711665	Heterogeneity and distribution of lipopolysaccharide in the cell wall of a gram-negative marine bacterium.	DiRienzo JM, Deneke CF, MacLeod RA	J Bacteriol	10.1128/jb.136.1.148-157.1978	1978	Cell Membrane/analysis, Cell Wall/analysis, Electrophoresis, Polyacrylamide Gel, Lipopolysaccharides/analysis, Polysaccharides, Bacterial/analysis, Pseudomonas/*analysis/growth & development/ultrastructure
Pathogenicity	809470	Reduced virulence of Pseudomonas aeruginosa grown in the presence of benzalkonium chloride.	Adair FW, Liauw HL, Geftic SG, Gelzer J	J Clin Microbiol	10.1128/jcm.1.2.175-179.1975	1975	Animals, Antigens, Bacterial, Benzalkonium Compounds/pharmacology, Conjunctivitis/etiology, Disease Models, Animal, Drug Resistance, Microbial, Immunization, Kidney Diseases/etiology, Mice, Pseudomonas Infections/etiology/prevention & control, Pseudomonas aeruginosa/drug effects/immunology/pathogenicity, Rabbits, Virulence
Metabolism	1444363	Enhanced octadecane dispersion and biodegradation by a Pseudomonas rhamnolipid surfactant (biosurfactant).	Zhang Y, Miller RM	Appl Environ Microbiol	10.1128/aem.58.10.3276-3282.1992	1992	Alkanes/chemistry/metabolism, Biodegradation, Environmental/drug effects, Glycolipids/biosynthesis/pharmacology, Hydrogen-Ion Concentration, Pseudomonas aeruginosa/metabolism, Rhamnose/biosynthesis/pharmacology, Surface Tension/drug effects	Pathogenicity
Biotechnology	2127724	[Microbial growth in parenteral nutrition. II. Effects of osmolality].	Vilchez Medina T, Montero Herrero CG, Garcia Curiel A, Lluch Colomer A, Rodriguez Cobacho A, Atienza Fernandez M	Nutr Hosp		1990	Bacteria/growth & development, Candida albicans/growth & development, Colony Count, Microbial, Food Microbiology, Food, Formulated, Osmolar Concentration, *Parenteral Nutrition
Pathogenicity	2425732	Gentamicin interaction with Pseudomonas aeruginosa cell envelope.	Martin NL, Beveridge TJ	Antimicrob Agents Chemother	10.1128/AAC.29.6.1079	1986	Cell Membrane/drug effects, Electrophoresis, Polyacrylamide Gel, Freeze Fracturing, Gentamicins/metabolism/pharmacology, Microscopy, Electron, Pseudomonas aeruginosa/drug effects/metabolism/ultrastructure, Sodium Dodecyl Sulfate, Spectrophotometry, Atomic, Staining and Labeling	Enzymology
Enzymology	2485358	[A microbial growth study in parenteral nutrition].	Vilchez Medina T, Montero Herrero CG, Garcia Curiel A, Atienza Fernandez M	Nutr Hosp		1989	Bacteria/growth & development/isolation & purification, Candida albicans/growth & development/isolation & purification, Colony Count, Microbial, Culture Media, Drug Contamination, *Parenteral Nutrition, Time Factors	Phylogeny
Metabolism	3085910	Lipopolysaccharide changes and cytoplasmic polyphosphate granule accumulation in Pseudomonas aeruginosa during growth on hexadecane.	Miguez CB, Beveridge TJ, Ingram JM	Can J Microbiol	10.1139/m86-049	1986	Alkanes/metabolism, Cell Membrane/ultrastructure, Culture Media, Cytoplasmic Granules/ultrastructure, Freeze Etching, Glucose/metabolism, Lipopolysaccharides/metabolism, Microscopy, Electron, Polyphosphates, Pseudomonas aeruginosa/*growth & development/metabolism/ultrastructure	Cultivation
Metabolism	3132316	Amikacin disrupts the cell envelope of Pseudomonas aeruginosa ATCC 9027.	Walker SG, Beveridge TJ	Can J Microbiol	10.1139/m88-003	1988	Amikacin/pharmacology, Bacterial Proteins/metabolism, Calcium/metabolism, Cell Membrane/metabolism/ultrastructure, Electrophoresis, Polyacrylamide Gel, Freeze Fracturing, Lipopolysaccharides/metabolism, Magnesium/metabolism, Microscopy, Electron, Phosphorus/metabolism, Pseudomonas aeruginosa/drug effects/metabolism/ultrastructure	Enzymology
Metabolism	4974394	Amino acid pool formation in Pseudomonas aeruginosa.	Kay WW, Gronlund AF	J Bacteriol	10.1128/jb.97.1.282-291.1969	1969	Amides/pharmacology, Amino Acids/metabolism, Arginine/metabolism, Carbon Isotopes, Chloramphenicol/pharmacology, Cold Temperature, Glutamates/metabolism, Glycine/metabolism, Histidine/metabolism, Kinetics, Membrane Transport Proteins/metabolism, Nitrogen/pharmacology, Proline/metabolism, Pseudomonas aeruginosa/metabolism, Serine/metabolism, Valine/metabolism	Enzymology
Cultivation	4992367	Release of alkaline phosphatase from cells of Pseudomonas aeruginosa by manipulation of cation concentration and of pH.	Cheng KJ, Ingram JM, Costerton JW	J Bacteriol	10.1128/jb.104.2.748-753.1970	1970	Alkaline Phosphatase/metabolism, Calcium Chloride/pharmacology, Chlorides, Culture Media, Cytoplasm, Enzyme Induction, Hydrogen-Ion Concentration, Magnesium/pharmacology, Osmosis, Potassium Chloride/pharmacology, Pseudomonas aeruginosa/drug effects/enzymology/growth & development, Sodium Chloride/pharmacology, Spectrophotometry, Sucrose/pharmacology, Tromethamine/pharmacology, Water/pharmacology	Metabolism
Phylogeny	6430349	Spectral properties of a mixture of fluorescent pigments produced by Pseudomonas aeruginosa.	MacDonald JC, Bishop GG	Biochim Biophys Acta	10.1016/0304-4165(84)90088-6	1984	Azotobacter, Chromatography, High Pressure Liquid, Hydrogen-Ion Concentration, Magnetic Resonance Spectroscopy, Pigments, Biological/analysis, Pseudomonas aeruginosa/analysis, Species Specificity, Spectrometry, Fluorescence/methods
Metabolism	6461406	Limited contribution of the outer-membrane penetration barrier towards intrinsic antibiotic resistance of Pseudomonas aeruginosa.	Scudamore RA, Goldner M	Can J Microbiol	10.1139/m82-022	1982	Anti-Bacterial Agents/metabolism/pharmacology, Carbenicillin/metabolism, Cell Membrane Permeability, Cephamycins/metabolism, Edetic Acid/pharmacology, Erythromycin/metabolism, Gentamicins/metabolism, Moxalactam, Penicillin Resistance, Pseudomonas aeruginosa/drug effects/metabolism, Tobramycin/metabolism	Pathogenicity
Metabolism	6810756	Penetration of the outer membrane of Pseudomonas aeruginosa by synergistic combinations of beta-lactam and aminoglycoside antibiotics.	Scudamore RA, Goldner M	Antimicrob Agents Chemother	10.1128/AAC.21.6.1007	1982	Aminoglycosides/metabolism/pharmacology, Anti-Bacterial Agents/metabolism/pharmacology, Cell Membrane/metabolism, Drug Combinations, Drug Synergism, Edetic Acid/pharmacology, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/metabolism, beta-Lactams/metabolism/pharmacology	Pathogenicity
Enzymology	6811119	Glycogen and various other polysaccharides stimulate the formation of exolipase by Pseudomonas aeruginosa.	Schulte G, Bohne L, Winkler U	Can J Microbiol	10.1139/m82-095	1982	Anti-Bacterial Agents/pharmacology, Glycogen/pharmacology, Lipase/biosynthesis, Polysaccharides/pharmacology, Pseudomonas aeruginosa/drug effects/enzymology/growth & development	Pathogenicity
Enzymology	7621801	Biosurfactant-facilitated remediation of metal-contaminated soils.	Miller RM	Environ Health Perspect	10.1289/ehp.95103s159	1995	Metals/isolation & purification, Molecular Weight, Porosity, Soil Pollutants/isolation & purification, Surface-Active Agents/*chemistry	Phylogeny
Metabolism	9008888	Evaluation of the biological containment system based on the Escherichia coli gef gene in Pseudomonas aeruginosa W51D.	Soberon-Chavez G	Appl Microbiol Biotechnol	10.1007/s002530050859	1996	Alkanesulfonic Acids/metabolism, Antibiosis/genetics, Bacterial Proteins/genetics/physiology, Bacterial Toxins, Blotting, Southern, DNA Transposable Elements, Environmental Microbiology, Escherichia coli/genetics, Escherichia coli Proteins, Gene Expression Regulation, Bacterial, Lac Operon/genetics, Membrane Proteins, Mutagenesis, Insertional, Pseudomonas aeruginosa/*genetics/metabolism, Tetracycline Resistance/genetics	Pathogenicity
Genetics	9588800	Structural and functional implications of sequence diversity of Pseudomonas aeruginosa genes oriC, ampC and fliC.	Spangenberg C, Montie TC, Tummler B	Electrophoresis	10.1002/elps.1150190414	1998	Bacterial Proteins, Base Sequence, DNA, Bacterial, Flagellin/genetics, Genes, Bacterial, Genetic Variation, Molecular Sequence Data, Pseudomonas aeruginosa/genetics, Replication Origin, Sequence Analysis, DNA, Sequence Homology, Nucleic Acid, beta-Lactamases/genetics	Transcriptome
Pathogenicity	10217320	Electron-microscopic study of the bactericidal effect of OPB-2045, a new mono-biguanide disinfectant produced from biguanide group compounds, against Pseudomonas aeruginosa.	Sakagami Y, Mimura M, Kajimura K, Yokoyama H, Nishimura H	J Pharm Pharmacol	10.1211/0022357991772141	1999	Anti-Infective Agents, Local/pharmacology, Biguanides/pharmacology, Colony Count, Microbial, Disinfectants/pharmacology, Dose-Response Relationship, Drug, Microbial Sensitivity Tests, Microscopy, Electron, Pseudomonas aeruginosa/drug effects/growth & development/ultrastructure
Pathogenicity	10540232	Comparative responses of Pseudomonas stutzeri and Pseudomonas aeruginosa to antibacterial agents.	Tattawasart U, Maillard JY, Furr JR, Russell AD	J Appl Microbiol	10.1046/j.1365-2672.1999.00811.x	1999	Anti-Bacterial Agents/pharmacology, Microbial Sensitivity Tests, Pseudomonas/drug effects, Pseudomonas aeruginosa/*drug effects, Species Specificity	Phylogeny
Metabolism	11476488	Phenanthrene degradation in soils co-inoculated with phenanthrene-degrading and biosurfactant-producing bacteria.	Dean SM, Jin Y, Cha DK, Wilson SV, Radosevich M	J Environ Qual	10.2134/jeq2001.3041126x	2001	Adsorption, Biodegradation, Environmental, Biological Availability, Glycolipids/chemistry, Phenanthrenes/metabolism/pharmacokinetics, Pseudomonas aeruginosa/physiology, Soil Pollutants/metabolism/pharmacokinetics, Surface-Active Agents/*chemistry	Enzymology
Pathogenicity	14573977	Antibacterial activity of intraocularly used liquids against two strains of Pseudomonas aeruginosa.	Economou-Stamatelopoulou C, Roussopoulos GP, Prouskas JC, Apostolopoulos M	Ophthalmologica	10.1159/000073074	2003	Anti-Bacterial Agents/pharmacology, Bicarbonates/pharmacology, Drug Combinations, Drug Evaluation, Drug Resistance, Bacterial, Fluorocarbons/pharmacology, Glutathione/pharmacology, Humans, Ophthalmic Solutions/pharmacology, Pseudomonas aeruginosa/drug effects, Silicone Oils/pharmacology
Metabolism	14602632	Aerobic denitrification of Pseudomonas aeruginosa monitored by online NAD(P)H fluorescence.	Chen F, Xia Q, Ju LK	Appl Environ Microbiol	10.1128/AEM.69.11.6715-6722.2003	2003	Aerobiosis, Anaerobiosis, Culture Media, Fluorescence, Fluorometry/methods, NADP/metabolism, Nitrates/metabolism, Online Systems, Oxygen/pharmacology, Oxygen Consumption, Pseudomonas aeruginosa/*growth & development/metabolism	Cultivation
Metabolism	14711632	Structure and characterization of flavolipids, a novel class of biosurfactants produced by Flavobacterium sp. strain MTN11.	Bodour AA, Guerrero-Barajas C, Jiorle BV, Malcomson ME, Paull AK, Somogyi A, Trinh LN, Bates RB, Maier RM	Appl Environ Microbiol	10.1128/AEM.70.1.114-120.2004	2004	Alkanes, Biodegradation, Environmental, Emulsifying Agents, Flavobacterium/growth & development/metabolism, Lipoproteins/chemistry/metabolism, Magnetic Resonance Spectroscopy, Micelles, Solubility, Surface Tension, Surface-Active Agents/chemistry/classification/*metabolism	Phylogeny
Pathogenicity	15085050	Preliminary evaluation of bioactive glass S53P4 as an endodontic medication in vitro.	Zehnder M, Soderling E, Salonen J, Waltimo T	J Endod	10.1097/00004770-200404000-00009	2004	Animals, Anti-Infective Agents, Local/pharmacology, Candida albicans/drug effects, Cattle, Colony Count, Microbial, Dentin/microbiology, Enterococcus faecalis/drug effects, Glass, Humans, Hydrogen-Ion Concentration, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Root Canal Irrigants/pharmacology, Streptococcus mutans/drug effects, Time Factors
Enzymology	15224748	Cadmium removal from contaminated soil by tunable biopolymers.	Prabhukumar G, Matsumoto M, Mulchandani A, Chen W	Environ Sci Technol	10.1021/es035150z	2004	Adsorption, Biopolymers/chemistry, Cadmium/isolation & purification, Chemical Precipitation, Soil Pollutants/*isolation & purification, Temperature	Phylogeny
Metabolism	15537923	Effect of surfactants on solubilization and degradation of phenanthrene under thermophilic conditions.	Wong JW, Fang M, Zhao Z, Xing B	J Environ Qual	10.2134/jeq2004.2015	2004	Bacillus/physiology, Biodegradation, Environmental, Biological Availability, Environmental Pollutants/metabolism, Phenanthrenes/chemistry/metabolism, Pseudomonas aeruginosa/physiology, Solubility, Surface-Active Agents/chemistry, Temperature
Enzymology	15551830	Solubilization and desorption of PAHs in soil-aqueous system by biosurfactants produced from Pseudomonas aeruginosa P-CG3 under thermophilic condition.	Cheng KY, Zhao ZY, Wong JW	Environ Technol	10.1080/09593332508618382	2004	Adsorption, Biodegradation, Environmental, Polycyclic Aromatic Hydrocarbons/chemistry/isolation & purification, Pseudomonas aeruginosa/chemistry, Soil Pollutants/isolation & purification, Solubility, *Surface-Active Agents, Temperature	Phylogeny
Pathogenicity	15587584	Allylthiosulfinate: beta-cyclodextrin inclusion complex: preparation, characterization and microbiological activity.	Nikolic V, Stankovic M, Kapor A, Nikolic Lj, Cvetkovic D, Stamenkovic J	Pharmazie		2004	Anti-Infective Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Crystallography, X-Ray, Disulfides, Drug Stability, Fungi/drug effects, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Solubility, Spectrophotometry, Infrared, Spectrophotometry, Ultraviolet, Spectroscopy, Fourier Transform Infrared, Sulfinic Acids/chemical synthesis/pharmacology, Thermogravimetry, beta-Cyclodextrins/chemical synthesis/pharmacology
Metabolism	16228188	Monitoring microaerobic denitrification of Pseudomonas aeruginosa by online NAD(P)H fluorescence.	Ju LK, Chen F, Xia Q	J Ind Microbiol Biotechnol	10.1007/s10295-005-0035-6	2005	Aerobiosis, Anaerobiosis, Culture Media, Fluorescence, NADP/metabolism, Nitrates/metabolism, Online Systems, Oxygen Consumption, Phenotype, Pseudomonas aeruginosa/classification/growth & development/metabolism	Cultivation
Biotechnology	16335227	[Evaluation of the antimicrobial action of honey against Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Escherichia coli, Salmonella enteritidis, Listeria monocytogenes and Aspergillus niger. Evaluation of its microbiological charge].	Estrada H, Gamboa Mdel M, Arias ML, Chaves C	Arch Latinoam Nutr		2005	Anti-Bacterial Agents/pharmacology, Colony Count, Microbial, Food Microbiology, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Honey/*microbiology, Microbial Sensitivity Tests	Pathogenicity
Phylogeny	16346357	Isolation of a Pseudomonas sp. Which Utilizes the Phosphonate Herbicide Glyphosate.	Moore JK, Braymer HD, Larson AD	Appl Environ Microbiol	10.1128/aem.46.2.316-320.1983	1983
Pathogenicity	16459482	Antimicrobial preservative effectiveness of natural peptide antibiotics.	Kamysz W, Turecka K	Acta Pol Pharm		2005	Amphibian Proteins/pharmacology, Anti-Bacterial Agents/pharmacology, Antimicrobial Cationic Peptides/pharmacology, Bacteria/drug effects, Benzalkonium Compounds/pharmacology, Microbial Sensitivity Tests, Preservatives, Pharmaceutical/pharmacology, Proteins/pharmacology
Enzymology	16554956	Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.	Chan E, Zhou S, Srikumar S, Duan W	Pharm Res	10.1007/s11095-006-9783-x	2006	Amikacin/pharmacokinetics/pharmacology/therapeutic use, Animals, Anti-Bacterial Agents/pharmacokinetics/pharmacology/therapeutic use, Area Under Curve, Drug Synergism, Half-Life, Male, Microbial Sensitivity Tests, Penicillins/pharmacology/therapeutic use, Piperacillin/pharmacokinetics/pharmacology/therapeutic use, Predictive Value of Tests, Pseudomonas Infections/drug therapy/microbiology, Pseudomonas aeruginosa/*drug effects, Rats, Rats, Sprague-Dawley, Survival Analysis	Pathogenicity
Pathogenicity	16910936	Microbiological study of cosmetic products during their use by consumers: health risk and efficacy of preservative systems.	Campana R, Scesa C, Patrone V, Vittoria E, Baffone W	Lett Appl Microbiol	10.1111/j.1472-765X.2006.01952.x	2006	Bacteria/drug effects/isolation & purification, Colony Count, Microbial, Cosmetics, Drug Contamination, Health, Humans, Preservatives, Pharmaceutical/*pharmacology, Risk	Enzymology
Pathogenicity	17044310	[Microbiological assessment of efficiency of antibacterial modified textiles].	Jakimiak B, Rohm-Rodowald E, Staniszewska M, Cieslak M, Malinowska G, Kaleta A	Rocz Panstw Zakl Hig		2006	Anti-Bacterial Agents/chemistry, Anti-Infective Agents, Local/pharmacology, Bedding and Linens, Cross Infection/prevention & control, Disinfectants/pharmacology, Drug Resistance, Microbial, Efficiency, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Humans, Laundering/standards, Microbial Sensitivity Tests/standards, Poland
Enzymology	17081555	Enhanced aqueous solubilization of tetrachloroethylene by a rhamnolipid biosurfactant.	Clifford JS, Ioannidis MA, Legge RL	J Colloid Interface Sci	10.1016/j.jcis.2006.10.026	2006	Glycolipids/chemistry, Hydrophobic and Hydrophilic Interactions, Micelles, Pseudomonas aeruginosa/chemistry, Solubility, Surface Properties, Surface-Active Agents/chemistry, Tetrachloroethylene/chemistry/isolation & purification, Water/chemistry, Water Pollutants, Chemical/isolation & purification	Phylogeny
Enzymology	17105155	Determination of the acid dissociation constant of the biosurfactant monorhamnolipid in aqueous solution by potentiometric and spectroscopic methods.	Lebron-Paler A, Pemberton JE, Becker BA, Otto WH, Larive CK, Maier RM	Anal Chem	10.1021/ac0608826	2006	Absorption, Acids/analysis, Glycolipids/analysis/chemistry, Hydrogen-Ion Concentration, Magnetic Resonance Spectroscopy/methods, Potentiometry/methods, Pseudomonas aeruginosa/chemistry, Solutions/chemistry, Spectroscopy, Fourier Transform Infrared/methods, Surface-Active Agents/chemistry/isolation & purification, Water/*chemistry	Phylogeny
Pathogenicity	17205689	[Investigation of the efficacy of electrolyzed acid water on the standard strains of some pathogenic microorganisms].	Ileri C, Sezen Y, Dimoglo A	Mikrobiyol Bul		2006	Candida albicans/drug effects/physiology, Chlorides/analysis, Disinfection/methods, Electrolysis, Hydrogen-Ion Concentration, Oxidation-Reduction, Pseudomonas aeruginosa/drug effects/physiology, Staphylococcus aureus/drug effects/physiology, Water/*chemistry/pharmacology
Metabolism	17898839	Production and characterization of polyhydroxyalkanoates in Pseudomonas aeruginosa ATCC 9027 from glucose, an unrelated carbon source.	Rojas-Rosas O, Villafana-Rojas J, Lopez-Dellamary FA, Nungaray-Arellano J, Gonzalez-Reynoso O	Can J Microbiol	10.1139/W07-023	2007	Biomass, Carbon/chemistry/metabolism, Glucose/chemistry/metabolism, Molecular Weight, Nuclear Magnetic Resonance, Biomolecular/methods, Polyhydroxyalkanoates/biosynthesis/chemistry/metabolism, Pseudomonas aeruginosa/chemistry/growth & development/metabolism	Biotechnology
Pathogenicity	18030606	Novel lipid and preservative-free propofol formulation: properties and pharmacodynamics.	Ravenelle F, Gori S, Le Garrec D, Lessard D, Luo L, Palusova D, Sneyd JR, Smith D	Pharm Res	10.1007/s11095-007-9471-5	2007	Animals, Chemistry, Pharmaceutical, Colony Count, Microbial, Drug Stability, Female, Particle Size, Propofol/chemistry/pharmacology, Rats, Rats, Sprague-Dawley, Sleep/drug effects
Pathogenicity	18708273	Synthesis, characterization and antibacterial activity of some triazole Mannich bases carrying diphenylsulfone moieties.	Almajan GL, Barbuceanu SF, Almajan ER, Draghici C, Saramet G	Eur J Med Chem	10.1016/j.ejmech.2008.07.003	2008	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Bacteria/drug effects, Mannich Bases/chemistry, Microbial Sensitivity Tests, Sulfones/chemistry, Triazoles/chemical synthesis/chemistry/*pharmacology
	19020934	Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus attachment patterns on glass surfaces with nanoscale roughness.	Mitik-Dineva N, Wang J, Truong VK, Stoddart P, Malherbe F, Crawford RJ, Ivanova EP	Curr Microbiol	10.1007/s00284-008-9320-8	2008	Bacterial Adhesion, Escherichia coli/chemistry/cytology/physiology, Glass/chemistry, Pseudomonas aeruginosa/chemistry/cytology/physiology, Staphylococcus aureus/chemistry/cytology/*physiology, Surface Properties
Enzymology	19256417	[Microbiological contamination and antimicrobial activity of cristalised cane sugar on some medically important microorganisms in Costa Rica].	Pujol V, Diaz J, Rodriguez E, Arias ML	Rev Biol Trop		2008	Anti-Bacterial Agents/pharmacology, Clostridium botulinum/isolation & purification, Costa Rica, Dietary Sucrose/pharmacology, Enterobacteriaceae/isolation & purification, Food Microbiology, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Microbial Sensitivity Tests, Saccharum/chemistry/*microbiology	Phylogeny
	19291044	Direct contact membrane method for evaluating preservative efficacy in solid cosmetics.	Tran AT, Hitchins AD, Collier SW	Int J Cosmet Sci	10.1111/j.1467-2494.1990.tb00533.x	1990
Pathogenicity	19356828	Copper(II) and uranyl(II) complexes with acylthiosemicarbazide: synthesis, characterization, antibacterial activity and effects on the growth of promyelocytic leukemia cells HL-60.	Angelusiu MV, Almajan GL, Rosu T, Negoiu M, Almajan ER, Roy J	Eur J Med Chem	10.1016/j.ejmech.2009.03.016	2009	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Antineoplastic Agents/chemical synthesis/chemistry/pharmacology, Bacteria/drug effects, Cell Proliferation/drug effects, Cell Survival/drug effects, Copper/chemistry, Electron Spin Resonance Spectroscopy, Electrons, HL-60 Cells, Humans, Leukemia/pathology, Ligands, Magnetics, Organometallic Compounds/chemical synthesis/chemistry/pharmacology, Semicarbazides/chemistry, Spectrophotometry, Infrared, Thermogravimetry, Uranium/*chemistry
Pathogenicity	19508298	Antimicrobial activity of lavender, tea tree and lemon oils in cosmetic preservative systems.	Kunicka-Styczynska A, Sikora M, Kalemba D	J Appl Microbiol	10.1111/j.1365-2672.2009.04372.x	2009	Anti-Infective Agents/pharmacology, Aspergillus niger/drug effects, Bacteria/drug effects, Candida/drug effects, Carbamates/pharmacology, Cosmetics/chemistry, Hydantoins/pharmacology, Lavandula/chemistry, Oils, Volatile/pharmacology, Plant Oils/pharmacology, Preservatives, Pharmaceutical/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Tea Tree Oil/pharmacology
Pathogenicity	19616347	Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.	Barbuceanu SF, Almajan GL, Saramet I, Draghici C, Tarcomnicu AI, Bancescu G	Eur J Med Chem	10.1016/j.ejmech.2009.06.021	2009	Anti-Bacterial Agents/chemistry/pharmacology, Bacteria/drug effects, Biphenyl Compounds/chemistry/pharmacology, Microbial Sensitivity Tests, Molecular Structure, Structure-Activity Relationship, Sulfones/chemistry/pharmacology, Triazoles/chemistry/pharmacology
Pathogenicity	19921329	In vitro synergistic activities of essential oils and surfactants in combination with cosmetic preservatives against Pseudomonas aeruginosa and Staphylococcus aureus.	Patrone V, Campana R, Vittoria E, Baffone W	Curr Microbiol	10.1007/s00284-009-9531-7	2009	Anti-Bacterial Agents/pharmacology, Drug Synergism, Humans, Microbial Sensitivity Tests, Oils, Volatile/pharmacology, Preservatives, Pharmaceutical/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Surface-Active Agents/pharmacology
Genetics	20107499	Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7.	Roy PH, Tetu SG, Larouche A, Elbourne L, Tremblay S, Ren Q, Dodson R, Harkins D, Shay R, Watkins K, Mahamoud Y, Paulsen IT	PLoS One	10.1371/journal.pone.0008842	2010	Anti-Bacterial Agents/pharmacology, Drug Resistance, Microbial/genetics, Drug Resistance, Multiple/genetics, Genome, Bacterial, Microbial Sensitivity Tests, Proteome, Pseudomonas aeruginosa/classification/drug effects/genetics/pathogenicity, Quorum Sensing, Virulence Factors/genetics	Proteome
Pathogenicity	20307919	New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.	Almajan GL, Barbuceanu SF, Saramet I, Draghici C	Eur J Med Chem	10.1016/j.ejmech.2010.02.057	2010	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Bacteria/drug effects, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Spectrophotometry, Infrared, Thiadiazines/chemical synthesis/chemistry/*pharmacology
Pathogenicity	20406376	Antimicrobial and antioxidant activities of Mexican oregano essential oils (Lippia graveolens H. B. K.) with different composition when microencapsulated in beta-cyclodextrin.	Arana-Sanchez A, Estarron-Espinosa M, Obledo-Vazquez EN, Padilla-Camberos E, Silva-Vazquez R, Lugo-Cervantes E	Lett Appl Microbiol	10.1111/j.1472-765X.2010.02837.x	2010	Anti-Bacterial Agents/analysis/pharmacology, Antioxidants/analysis/pharmacology, Bacteria/drug effects, Drug Compounding/methods, Lippia/chemistry, Oils, Volatile/analysis/pharmacology, Plant Oils/analysis/pharmacology, beta-Cyclodextrins/chemistry
Pathogenicity	20510589	P(4-VP) based nanoparticles and composites with dual action as antimicrobial materials.	Ozay O, Akcali A, Otkun MT, Silan C, Aktas N, Sahiner N	Colloids Surf B Biointerfaces	10.1016/j.colsurfb.2010.05.013	2010	Absorption/drug effects, Anti-Infective Agents/pharmacology, Bacteria/drug effects, Emulsions, Methacrylates/chemistry/pharmacology, Microbial Sensitivity Tests, Nanocomposites/chemistry/ultrastructure, Nanoparticles/chemistry/ultrastructure, Particle Size, Polymers/pharmacology, Polyvinyls/*pharmacology, Spectroscopy, Fourier Transform Infrared
	20812507	[Structural components and peculiarities of Pseudomonas aeruginosa biofilm organization].	Balko OB, Avdieieva LV	Mikrobiol Z		2010	Biofilms/growth & development, Microscopy, Confocal, Models, Biological, Pseudomonas aeruginosa/growth & development/*ultrastructure
Metabolism	21208798	Effects of rhamnolipids on cell surface hydrophobicity of PAH degrading bacteria and the biodegradation of phenanthrene.	Zhao Z, Selvam A, Wong JW	Bioresour Technol	10.1016/j.biortech.2010.11.088	2010	Analysis of Variance, Bacillus subtilis/metabolism, Biodegradation, Environmental/drug effects, Cell Membrane/drug effects/metabolism, Glycolipids/metabolism/pharmacology, Hydrophobic and Hydrophilic Interactions/drug effects, Phenanthrenes/metabolism, Pseudomonas aeruginosa/metabolism, Surface-Active Agents/metabolism/*pharmacology	Pathogenicity
Pathogenicity	21255080	Comparative efficacies of contact lens disinfecting solutions against Pseudomonas aeruginosa.	Amiri MA, Mohammadinia M, Tabatabaee M, Askarizadeh F, Behgozin A	Clin Exp Optom	10.1111/j.1444-0938.2010.00576.x	2011	Colony Count, Microbial, Contact Lens Solutions/pharmacology, Contact Lenses/microbiology, Eye Infections, Bacterial/microbiology/prevention & control, Humans, Pseudomonas Infections/microbiology/prevention & control, Pseudomonas aeruginosa/*drug effects/growth & development
Pathogenicity	21466954	Hydroalcoholic extract based-ointment from Punica granatum L. peels with enhanced in vivo healing potential on dermal wounds.	Hayouni EA, Miled K, Boubaker S, Bellasfar Z, Abedrabba M, Iwaski H, Oku H, Matsui T, Limam F, Hamdi M	Phytomedicine	10.1016/j.phymed.2011.02.011	2011	Animals, Anti-Infective Agents/pharmacology, Antioxidants/metabolism, Chromatography, High Pressure Liquid, Female, Guinea Pigs, Lythraceae/chemistry, Male, Microbial Sensitivity Tests/methods, Ointments/chemistry/pharmacology, Plant Extracts/administration & dosage/chemistry/pharmacology, Skin/drug effects/injuries, Tensile Strength, Wound Healing/drug effects, Wounds and Injuries/*drug therapy	Metabolism
Pathogenicity	21556922	The influence of nanoscopically thin silver films on bacterial viability and attachment.	Ivanova EP, Hasan J, Truong VK, Wang JY, Raveggi M, Fluke C, Crawford RJ	Appl Microbiol Biotechnol	10.1007/s00253-011-3195-5	2011	Anti-Bacterial Agents/pharmacology, Bacterial Adhesion/drug effects, Microbial Viability/drug effects, Motion Pictures, Nanotechnology, Pseudomonas aeruginosa/drug effects/physiology, Silver/pharmacology, Staphylococcus aureus/*drug effects/physiology
Pathogenicity	21623253	Importance of rub and rinse in use of multipurpose contact lens solution.	Zhu H, Bandara MB, Vijay AK, Masoudi S, Wu D, Willcox MD	Optom Vis Sci	10.1097/OPX.0b013e31821bf976	2011	Bacteria/drug effects/growth & development, Coated Materials, Biocompatible, Colony Count, Microbial, Contact Lens Solutions/pharmacology, Contact Lenses, Hydrophilic/microbiology, Disinfection/methods, Humans, Hydrogels, Reproducibility of Results, Silicones
Pathogenicity	21624484	In vitro assay of the antimicrobial activity of kephir against bacterial and fungal strains.	Chifiriuc MC, Cioaca AB, Lazar V	Anaerobe	10.1016/j.anaerobe.2011.04.020	2011	Anti-Infective Agents/metabolism/pharmacology, Bacteria/drug effects/growth & development, Candida albicans/drug effects/growth & development, Dairy Products, Humans, Microbial Sensitivity Tests	Metabolism
Pathogenicity	22094301	Contact lens disinfecting solutions antibacterial efficacy: comparison between clinical isolates and the standard ISO ATCC strains of Pseudomonas aeruginosa and Staphylococcus aureus.	Mohammadinia M, Rahmani S, Eslami G, Ghassemi-Broumand M, Aghazadh Amiri M, Aghaie G, Tabatabaee SM, Taheri S, Behgozin A	Eye (Lond)	10.1038/eye.2011.284	2011	Anti-Bacterial Agents/pharmacology, Colony Count, Microbial, Contact Lens Solutions/pharmacology/standards, Contact Lenses/microbiology, Disinfection/methods/standards, Humans, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Time Factors
Pathogenicity	22282519	Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7.	Morita Y, Tomida J, Kawamura Y	Microbiology (Reading)	10.1099/mic.0.054320-0	2012	Amino Acid Sequence, Aminoglycosides/pharmacology, Anti-Bacterial Agents/pharmacology, Bacterial Proteins/metabolism, Base Sequence, Cloning, Molecular, DNA, Bacterial/genetics, Drug Resistance, Multiple, Bacterial/genetics, Gene Knockout Techniques, Genetic Complementation Test, Membrane Transport Proteins/metabolism, Microbial Sensitivity Tests, Molecular Sequence Data, Pseudomonas aeruginosa/drug effects/genetics, Sequence Analysis, DNA	Metabolism
Pathogenicity	22401914	Semisynthesis and antimicrobial activity of novel guttiferone-A derivatives.	Dias KS, Januario JP, D' Dego JL, Dias AL, dos Santos MH, Camps I, Coelho LF, Viegas C Jr	Bioorg Med Chem	10.1016/j.bmc.2012.02.023	2012	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Antifungal Agents/chemical synthesis/chemistry/pharmacology, Bacteria/drug effects/growth & development, Benzophenones/chemical synthesis/chemistry/pharmacology, Cell Survival/drug effects, Dose-Response Relationship, Drug, Fungi/*drug effects/growth & development, Humans, Leukocytes, Mononuclear/cytology/drug effects, Microbial Sensitivity Tests, Molecular Conformation, Stereoisomerism, Structure-Activity Relationship
Pathogenicity	22516425	Synthesis and characterization of some new complexes of Cu(II), Ni(II) and V(IV) with Schiff base derived from indole-3-carboxaldehyde. Biological activity on prokaryotes and eukaryotes.	Rosu T, Pahontu E, Ilies DC, Georgescu R, Mocanu M, Leabu M, Shova S, Gulea A	Eur J Med Chem	10.1016/j.ejmech.2012.03.046	2012	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Antifungal Agents/chemical synthesis/chemistry/pharmacology, Antineoplastic Agents/chemical synthesis/chemistry/pharmacology, Bacteria/drug effects, Cell Proliferation/drug effects, Chemistry Techniques, Synthetic, Copper/chemistry, Fungi/drug effects, HeLa Cells, Humans, Indoles/chemistry, Metals, Heavy/chemistry, Nickel/chemistry, Organometallic Compounds/chemical synthesis/chemistry/pharmacology, Schiff Bases/chemistry, Vanadium/chemistry
Pathogenicity	22966546	In-vivo and in-vitro biocompatibility evaluations of silver nanoparticles with antimicrobial activity.	Han DW, Woo YI, Lee MH, Lee JH, Lee J, Park JC	J Nanosci Nanotechnol	10.1166/jnn.2012.6367	2012	Animals, Anti-Bacterial Agents/adverse effects/pharmacology, Bacterial Physiological Phenomena/drug effects, Biocompatible Materials/adverse effects/pharmacology, CHO Cells, Cricetinae, Cricetulus, Lethal Dose 50, Materials Testing, Metal Nanoparticles/*administration & dosage/adverse effects, Mice
Pathogenicity	23157022	Antimicrobial activity of blended essential oil preparation.	Tadtong S, Suppawat S, Tintawee A, Saramas P, Jareonvong S, Hongratanaworakit T	Nat Prod Commun		2012	Algorithms, Anti-Bacterial Agents/pharmacology, Anti-Infective Agents, Antifungal Agents/pharmacology, Bacteria/drug effects, Fungi/drug effects, Gas Chromatography-Mass Spectrometry, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Microbial Sensitivity Tests, Oils, Volatile/pharmacology, Plants, Medicinal/chemistry
Metabolism	23523771	Biochemical characterization and evaluation of potent inhibitors of the Pseudomonas aeruginosa PA01 acetohydroxyacid synthase.	Cho JH, Lee MY, Baig IA, Ha NR, Kim J, Yoon MY	Biochimie	10.1016/j.biochi.2013.03.007	2013	Acetolactate Synthase/antagonists & inhibitors/metabolism, Anti-Bacterial Agents/pharmacology, Bacterial Proteins/antagonists & inhibitors/genetics/metabolism, Hydrogen Bonding, Hydrogen-Ion Concentration, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/*enzymology, Temperature	Enzymology
Metabolism	23586834	Use of a greasy effluent floater treatment station from the slaughterhouse for biosurfactant production.	Borges Wda S, Cardoso VL, de Resende MM	Biotechnol Appl Biochem	10.1002/bab.1018	2012	Abattoirs, Bioreactors, Fats/chemistry, Glycolipids/metabolism, Medical Waste Disposal, Pseudomonas aeruginosa/metabolism, Surface-Active Agents/*chemical synthesis/metabolism	Biotechnology
Pathogenicity	23844805	Cis-9-octadecenoic acid from the rhizospheric bacterium Stenotrophomonas maltophilia BJ01 shows quorum quenching and anti-biofilm activities.	Singh VK, Kavita K, Prabhakaran R, Jha B	Biofouling	10.1080/08927014.2013.807914	2013	Biofilms/drug effects, Biofouling/prevention & control, Gas Chromatography-Mass Spectrometry, Microscopy, Atomic Force, Microscopy, Electron, Scanning, Oleic Acid/chemistry/pharmacology, Pseudomonas aeruginosa/physiology, Quorum Sensing/drug effects, Spectrometry, Mass, Electrospray Ionization, Stenotrophomonas maltophilia/chemistry
Metabolism	23943464	Statistical screening of medium components for recombinant production of Pseudomonas aeruginosa ATCC 9027 rhamnolipids by nonpathogenic cell factory Pseudomonas putida KT2440.	Setoodeh P, Jahanmiri A, Eslamloueyan R, Niazi A, Ayatollahi SS, Aram F, Mahmoodi M, Hortamani A	Mol Biotechnol	10.1007/s12033-013-9693-1	2014	Bacterial Proteins/genetics/metabolism, Culture Media/chemistry/pharmacology, Glycerol/pharmacology, Glycolipids/biosynthesis, Peptones/pharmacology, Pseudomonas aeruginosa/metabolism, Pseudomonas putida/genetics/metabolism	Biotechnology
	24632157	Green synthesis of silver nanoparticles using Delphinium denudatum root extract exhibits antibacterial and mosquito larvicidal activities.	Suresh G, Gunasekar PH, Kokila D, Prabhu D, Dinesh D, Ravichandran N, Ramesh B, Koodalingam A, Vijaiyan Siva G	Spectrochim Acta A Mol Biomol Spectrosc	10.1016/j.saa.2014.02.030	2014	Aedes, Animals, Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Bacteria/growth & development, Delphinium/chemistry, Dengue/transmission, Dengue Virus, Insect Vectors, Insecticides/chemical synthesis/chemistry/pharmacology, Larva, Metal Nanoparticles/chemistry, Pest Control/methods, Plant Extracts/chemistry, Plant Roots/chemistry, Silver/chemistry/pharmacology
Pathogenicity	24884949	Manuka honey treatment of biofilms of Pseudomonas aeruginosa results in the emergence of isolates with increased honey resistance.	Camplin AL, Maddocks SE	Ann Clin Microbiol Antimicrob	10.1186/1476-0711-13-19	2014	Anti-Bacterial Agents/metabolism, Biofilms/drug effects/growth & development, Drug Resistance, Bacterial, Honey, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/growth & development/physiology	Metabolism
	25176324	Bioluminescence-based measurement of viability of Pseudomonas aeruginosa ATCC 9027 harbouring plasmid-based lux genes under the control of constitutive promoters.	Shah N, Naseby DC	J Appl Microbiol	10.1111/jam.12635	2014	Gene Expression, Luminescent Measurements/methods, Microbial Viability, Plasmids/genetics, Promoter Regions, Genetic, Pseudomonas aeruginosa/*genetics/growth & development
Biotechnology	25293767	Assessment of tolerance induction by Origanum vulgare L. essential oil or carvacrol in Pseudomonas aeruginosa cultivated in a meat-based broth and in a meat model.	da Silva Luz I, Gomes-Neto NJ, Magnani M, de Souza EL	Food Sci Technol Int	10.1177/1082013214554467	2014	Animals, Anti-Bacterial Agents/pharmacology, Cattle, Cymenes, Drug Resistance, Bacterial, Food Microbiology, Meat/microbiology, Microbial Sensitivity Tests, Microbial Viability/drug effects, Monoterpenes/pharmacology, Oils, Volatile/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects/growth & development	Pathogenicity
Proteome	25369543	Insights into Pseudomonas aeruginosa ATCC9027 resistance to isothiazolones through proteomics.	Zhou G, Shi QS, Huang XM, Xie XB, Chen YB	Microb Drug Resist	10.1089/mdr.2014.0113	2014	ATP-Binding Cassette Transporters/genetics, Anti-Bacterial Agents/pharmacology, Bacterial Proteins/genetics, Drug Resistance, Bacterial/genetics, Proteome/genetics, Proteomics/methods, Pseudomonas aeruginosa/genetics, Thiazoles/pharmacology
Metabolism	25528238	Effect of low-concentration rhamnolipid on adsorption of Pseudomonas aeruginosa ATCC 9027 on hydrophilic and hydrophobic surfaces.	Zhong H, Jiang Y, Zeng G, Liu Z, Liu L, Liu Y, Yang X, Lai M, He Y	J Hazard Mater	10.1016/j.jhazmat.2014.11.050	2014	Adsorption, Alkanes/metabolism, Glass/chemistry, Glucose/metabolism, Glycolipids/chemistry, Hydrophobic and Hydrophilic Interactions, Pseudomonas aeruginosa/chemistry/growth & development/metabolism, Surface Properties, Surface-Active Agents/*chemistry
Enzymology	25618377	Validation of constitutively expressed bioluminescent Pseudomonas aeruginosa as a rapid microbiological quantification tool.	Shah N, Naseby DC	Biosens Bioelectron	10.1016/j.bios.2015.01.008	2015	Biosensing Techniques, Limit of Detection, Luminescent Measurements, Pseudomonas aeruginosa/chemistry/*isolation & purification	Phylogeny
Pathogenicity	25655077	Expression of recombinant Arabian camel lactoferricin-related peptide in Pichia pastoris and its antimicrobial identification.	Chahardooli M, Niazi A, Aram F, Sohrabi SM	J Sci Food Agric	10.1002/jsfa.7125	2015	Amino Acid Sequence, Animals, Anti-Infective Agents/pharmacology, Bacillus subtilis/drug effects, Base Sequence, Camelus, Candida albicans/drug effects, Drug Stability, Escherichia coli/drug effects, Gene Expression, Hot Temperature, Lactoferrin/biosynthesis/chemistry/genetics/pharmacology, Microbial Sensitivity Tests, Molecular Sequence Data, Peptides/genetics/pharmacology, Pichia/*metabolism, Pseudomonas aeruginosa/drug effects, Recombinant Proteins/biosynthesis/genetics/pharmacology, Saudi Arabia, Sequence Alignment, Staphylococcus aureus/drug effects	Stress
Metabolism	25837563	Effects of biosurfactant-producing bacteria on biodegradation and transport of phenanthrene in subsurface soil.	Chang JS, Cha DK, Radosevich M, Jin Y	J Environ Sci Health A Tox Hazard Subst Environ Eng	10.1080/10934529.2015.994967	2015	Biodegradation, Environmental, Phenanthrenes/metabolism, Pseudomonas aeruginosa/metabolism, Soil Microbiology, Soil Pollutants/metabolism, Surface-Active Agents/metabolism
Enzymology	26019629	Rapid identification of Pseudomonas aeruginosa by pulsed-field gel electrophoresis.	Selim S, El Kholy I, Hagagy N, El Alfay S, Aziz MA	Biotechnol Biotechnol Equip	10.1080/13102818.2014.981065	2014
	26029671	Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance.	Ayaz M, Subhan F, Ahmed J, Khan AU, Ullah F, Ullah I, Ali G, Syed NI, Hussain S	J Biol Res (Thessalon)	10.1186/s40709-015-0028-1	2015
	26220579	Corneal Biofilms: From Planktonic to Microcolony Formation in an Experimental Keratitis Infection with Pseudomonas Aeruginosa.	Saraswathi P, Beuerman RW	Ocul Surf	10.1016/j.jtos.2015.07.001	2015	Animals, Biofilms, Colony Count, Microbial, Cornea/microbiology/ultrastructure, Disease Models, Animal, Eye Infections, Bacterial/microbiology/pathology, Keratitis/microbiology/pathology, Mice, Mice, Inbred C57BL, Microscopy, Confocal, Microscopy, Electron, Scanning Transmission, Pseudomonas Infections/microbiology/pathology, Pseudomonas aeruginosa/physiology
Pathogenicity	26344590	Synthesis, electronic properties, antioxidant and antibacterial activity of some new benzimidazoles.	Mavrova ATs, Yancheva D, Anastassova N, Anichina K, Zvezdanovic J, Djordjevic A, Markovic D, Smelcerovic A	Bioorg Med Chem	10.1016/j.bmc.2015.08.029	2015	Anti-Bacterial Agents/chemical synthesis/pharmacology, Antioxidants/chemistry/pharmacology, Benzimidazoles/chemistry/pharmacology, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Lipid Peroxidation/drug effects, Microbial Sensitivity Tests, Molecular Conformation, Stereoisomerism, Structure-Activity Relationship, Thermodynamics
Pathogenicity	26347298	Identification of an antibacterial protein by functional screening of a human oral metagenomic library.	Arivaradarajan P, Warburton PJ, Paramasamy G, Nair SP, Allan E, Mullany P	FEMS Microbiol Lett	10.1093/femsle/fnv142	2015	Aldehyde Oxidoreductases/genetics, Amino Acid Sequence, Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology, Bacillus subtilis/drug effects, Bacteria/drug effects, Bacterial Proteins/chemistry/isolation & purification/pharmacology, Chromosomes, Artificial, Bacterial, Cloning, Molecular, Dental Plaque/microbiology, Escherichia coli/genetics, Escherichia coli K12/drug effects, Genetic Vectors, Genomic Library, Humans, Lactobacillus casei/drug effects, Metagenome, Molecular Sequence Data, Mutagenesis, Neisseria/chemistry, Plasmids, Pseudomonas aeruginosa/drug effects, Saliva/*microbiology, Sequence Analysis, DNA, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects	Enzymology
Enzymology	26408871	Microbial spoilage, instability risk of antacid suspension in the presence of commonly used preservative system.	Khan JA, Khan IU, Iqbal Z, Nasir F, Muhammad S, Hannan PA, Ullah I	Pak J Pharm Sci		2015	Antacids/chemistry, Bacteria/isolation & purification, Chemistry, Pharmaceutical, Drug Contamination, Drug Stability, Preservatives, Pharmaceutical/*pharmacology, Suspensions, Viscosity	Phylogeny
Metabolism	26413070	Biosurfactant production by Pseudomonas aeruginosain kefir and fish meal.	Kaskatepe B, Yildiz S, Gumustas M, Ozkan SA	Braz J Microbiol	10.1590/S1517-838246320140727	2015	Cultured Milk Products/microbiology, Fish Products/microbiology, Glycolipids/metabolism, Pseudomonas aeruginosa/isolation & purification/metabolism, Soil Microbiology, Soil Pollutants, Surface-Active Agents/*metabolism, Turkey, Ultraviolet Rays	Biotechnology
Genetics	26514765	Draft Genome Sequence of Pseudomonas aeruginosa ATCC 9027 (DSM 1128), an Important Rhamnolipid Surfactant Producer and Sterility Testing Strain.	Mai-Prochnow A, Bradbury M, Murphy AB	Genome Announc	10.1128/genomeA.01259-15	2015
Pathogenicity	26529040	Inhibitory Effects of 2,2'-Dipyridyl and 1,2,3,4,6-Penta-O-Galloyl-b-D-Glucopyranose on Biofilm Formation in Contact Lens Cases.	Cho P, Shi GS, Boost M	Invest Ophthalmol Vis Sci	10.1167/iovs.15-17723	2015	2,2'-Dipyridyl/pharmacology, Biofilms/drug effects/growth & development, Contact Lens Solutions/pharmacology, Contact Lenses/microbiology, Eye Infections, Bacterial/microbiology/prevention & control, Humans, Hydrolyzable Tannins/*pharmacology, Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors
Pathogenicity	26722821	Effect of low-concentration rhamnolipid on transport of Pseudomonas aeruginosa ATCC 9027 in an ideal porous medium with hydrophilic or hydrophobic surfaces.	Zhong H, Liu G, Jiang Y, Brusseau ML, Liu Z, Liu Y, Zeng G	Colloids Surf B Biointerfaces	10.1016/j.colsurfb.2015.11.024	2015	Alkanes/metabolism, Bacterial Adhesion/drug effects, Biodegradation, Environmental, Biological Transport/drug effects, Cell Membrane/chemistry/drug effects, Glass, Glucose/metabolism, Glycolipids/pharmacology, Hydrophobic and Hydrophilic Interactions, Movement/drug effects, Osmolar Concentration, Porosity, Pseudomonas aeruginosa/*drug effects/growth & development/metabolism, Surface Properties	Metabolism
Pathogenicity	26878297	A novel approach to antibiofilm susceptibility testing using a thermo-reversible matrix.	Taylor BJ, Marsh LL, Nosworthy JO, Williams DW	J Wound Care	10.12968/jowc.2016.25.2.62	2016	Anti-Bacterial Agents/pharmacology/therapeutic use, Anti-Infective Agents/pharmacology/therapeutic use, Bacterial Infections/drug therapy, Biguanides/pharmacology/therapeutic use, Biofilms/drug effects, Carbonates/therapeutic use, Humans, Imines, Microbial Sensitivity Tests, Povidone-Iodine/pharmacology/therapeutic use, Pseudomonas aeruginosa/*drug effects, Pyridines/pharmacology/therapeutic use, Silver Compounds/therapeutic use
	27005666	Ciprofloxacin-Induced Antibacterial Activity Is Atteneuated by Pretreatment with Antioxidant Agents.	Masadeh MM, Alzoubi KH, Al-Azzam SI, Khabour OF, Al-Buhairan AM	Pathogens	10.3390/pathogens5010028	2016
Pathogenicity	27113589	Effect of Mono and Di-rhamnolipids on Biofilms Pre-formed by Bacillus subtilis BBK006.	De Rienzo MA, Martin PJ	Curr Microbiol	10.1007/s00284-016-1046-4	2016	Bacillus subtilis/drug effects/genetics/physiology, Biofilms/drug effects, Burkholderia/drug effects/physiology, Glycolipids/chemistry/pharmacology, Pseudomonas aeruginosa/drug effects/physiology, Surface-Active Agents/chemistry/*pharmacology
	27189374	Comparison of the compact dry TC method with the standard method ISO 21149:2006 for determining aerobic colony counts in cosmetic emulsion.	De Vaugelade S, Aime M, Farcette N, Maurel E, Lacour T, Thomas C, Bouchonnet S, Pirnay S	Int J Cosmet Sci	10.1111/ics.12343	2016	Colony Count, Microbial, Cosmetics, *Emulsions, Oxidation-Reduction
Pathogenicity	27307973	Modulation of antibiotic resistance in Pseudomonas aeruginosa by ZnO nanoparticles.	Bayroodi E, Jalal R	Iran J Microbiol		2016
Pathogenicity	27438008	A bactericidal calix[4]arene-based nanoconstruct with amplified NO photorelease.	Di Bari I, Picciotto R, Granata G, Blanco AR, Consoli GM, Sortino S	Org Biomol Chem	10.1039/c6ob01305h	2016	Anti-Bacterial Agents/chemistry/pharmacology, Calixarenes/chemistry/pharmacology, Hydrophobic and Hydrophilic Interactions, Micelles, Nitric Oxide/chemistry, Nitrobenzenes/chemical synthesis/chemistry, Phenols/chemistry/pharmacology, Photochemical Processes, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects
Pathogenicity	27498831	Antimicrobial evaluation of selected naturally occurring oxyprenylated secondary metabolites.	Di Giulio M, Genovese S, Fiorito S, Epifano F, Nostro A, Cellini L	Nat Prod Res	10.1080/14786419.2015.1079908	2015	1-Propanol/chemistry/pharmacology, Anti-Bacterial Agents/pharmacology, Anti-Infective Agents/chemistry/pharmacology, Biofilms/drug effects, Candida albicans/drug effects, Drug Evaluation, Preclinical/methods, Escherichia coli/drug effects, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects/physiology, *Secondary Metabolism, Staphylococcus aureus/drug effects/physiology, Staphylococcus epidermidis/drug effects/physiology, Terpenes/chemistry/pharmacology	Metabolism
Metabolism	27566690	Pseudomonas aeruginosa ATCC 9027 is a non-virulent strain suitable for mono-rhamnolipids production.	Grosso-Becerra MV, Gonzalez-Valdez A, Granados-Martinez MJ, Morales E, Servin-Gonzalez L, Mendez JL, Delgado G, Morales-Espinosa R, Ponce-Soto GY, Cocotl-Yanez M, Soberon-Chavez G	Appl Microbiol Biotechnol	10.1007/s00253-016-7789-9	2016	Animals, Decanoates/metabolism, Disease Models, Animal, Drug Resistance, Bacterial, Genome, Bacterial, Metabolic Engineering, Metabolic Networks and Pathways/genetics, Mice, Operon, Plasmids, Pseudomonas Infections/microbiology, Pseudomonas aeruginosa/genetics/metabolism/pathogenicity, Rhamnose/analogs & derivatives/metabolism, Sequence Analysis, DNA, Surface-Active Agents/metabolism, Virulence	Genetics
Pathogenicity	27769938	A bioactivity guided study on the antibacterial activity of Hertia cheirifolia L. extracts.	Majouli K, Hamdi A, Msaada K, Kenani A	Microb Pathog	10.1016/j.micpath.2016.10.015	2016	Acetates/chemistry, Anti-Bacterial Agents/chemistry/pharmacology, Chromatography, High Pressure Liquid/methods, Cinnamates/chemistry, Flavonoids/chemistry, Flavonols, Flowers/chemistry, Gallic Acid/chemistry, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Microbial Sensitivity Tests/methods, Phenol/chemistry, Plant Extracts/pharmacology, Plant Roots/chemistry, Plant Stems/chemistry, Tracheophyta/chemistry, Tunisia
Metabolism	27773441	Effect of rhamnolipid solubilization on hexadecane bioavailability: enhancement or reduction?	Liu Y, Zeng G, Zhong H, Wang Z, Liu Z, Cheng M, Liu G, Yang X, Liu S	J Hazard Mater	10.1016/j.jhazmat.2016.10.025	2016	Alkanes/chemistry/pharmacokinetics, Biological Availability, Glycolipids/chemistry, Pseudomonas aeruginosa/metabolism, Pseudomonas putida/metabolism, Solubility	Enzymology
Pathogenicity	28164707	Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo Dragon) by Large-Scale Analyses and De-Novo-Assisted Sequencing Using Electron-Transfer Dissociation Mass Spectrometry.	Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML	J Proteome Res	10.1021/acs.jproteome.6b00857	2017	Animals, Antimicrobial Cationic Peptides/blood/genetics/isolation & purification/pharmacology, Humans, Lizards/blood, Mass Spectrometry, Pseudomonas aeruginosa/drug effects/pathogenicity, Saliva/chemistry, Staphylococcus aureus/drug effects/pathogenicity, Transcriptome/*genetics	Enzymology
Pathogenicity	28544922	Efficacy of benzalkonium chloride against bioluminescent P. aeruginosa ATCC9027 constructs.	Shah N, Naseby DC	Biosens Bioelectron	10.1016/j.bios.2017.04.029	2017	Anti-Infective Agents, Local/analysis/pharmacology, Benzalkonium Compounds/analysis/pharmacology, Biosensing Techniques/economics/methods, Humans, Luminescence, Luminescent Measurements/economics/methods, Microbial Sensitivity Tests, Preservatives, Pharmaceutical/analysis/pharmacology, Pseudomonas Infections/prevention & control, Pseudomonas aeruginosa/chemistry/cytology/*drug effects
Metabolism	28560883	A deletion mutation in nfxB of in vitro-induced moxifloxacin-resistant Pseudomonas aeruginosa confers multidrug resistance.	Thai VC, Pham HV, Nguyen DNM, Lambert P, Nguyen TTH	Acta Microbiol Immunol Hung	10.1556/030.64.2017.012	2017	Anti-Bacterial Agents/pharmacology, Bacterial Proteins/genetics/metabolism, DNA-Binding Proteins/genetics/metabolism, Drug Resistance, Multiple, Bacterial/genetics, Fluoroquinolones/pharmacology, Gene Deletion, Gene Expression Regulation, Bacterial/physiology, Moxifloxacin, Pseudomonas aeruginosa/drug effects/genetics, Transcription Factors/genetics/metabolism	Pathogenicity
Pathogenicity	28587291	In Vitro Evaluation of the Antioxidant, Cytoprotective, and Antimicrobial Properties of Essential Oil from Pistacia vera L. Variety Bronte Hull.	Smeriglio A, Denaro M, Barreca D, Calderaro A, Bisignano C, Ginestra G, Bellocco E, Trombetta D	Int J Mol Sci	10.3390/ijms18061212	2017	Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology, Antioxidants/chemistry/isolation & purification/pharmacology, Bacteria/drug effects, Bacterial Infections/drug therapy, Cytoprotection/drug effects, Humans, Lymphocytes/drug effects, Oils, Volatile/chemistry/isolation & purification/pharmacology, Pistacia/*chemistry	Enzymology
	28737038	Evolution of Aggregate Structure in Solutions of Anionic Monorhamnolipids: Experimental and Computational Results.	Eismin RJ, Munusamy E, Kegel LL, Hogan DE, Maier RM, Schwartz SD, Pemberton JE	Langmuir	10.1021/acs.langmuir.7b00078	2017
Pathogenicity	28756196	Inhibition of bacterial biofilms by carboxymethyl chitosan combined with silver, zinc and copper salts.	Goncalves RC, da Silva DP, Signini R, Naves PLF	Int J Biol Macromol	10.1016/j.ijbiomac.2017.07.048	2017	Animals, Artemia, Bacteria/drug effects, Biofilms/drug effects/growth & development, Chitosan/analogs & derivatives/chemistry/pharmacology/toxicity, Copper/chemistry, Metals, Heavy/chemistry, Microbial Sensitivity Tests, Silver/chemistry, Sulfates/chemistry, Zinc/chemistry
	28929050	Synergistic effect of Carum copticum and Mentha piperita essential oils with ciprofloxacin, vancomycin, and gentamicin on Gram-negative and Gram-positive bacteria.	Talei GR, Mohammadi M, Bahmani M, Kopaei MR	Int J Pharm Investig	10.4103/jphi.JPHI_12_17	2017
	28943669	Effect of low-concentration rhamnolipid biosurfactant on Pseudomonas aeruginosa transport in natural porous media.	Liu G, Zhong H, Jiang Y, Brusseau ML, Huang J, Shi L, Liu Z, Liu Y, Zeng G	Water Resour Res	10.1002/2016WR019832	2017
	29081676	Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin.	Masadeh MM, Alzoubi KH, Al-Azzam SI, Al-Buhairan AM	Clin Pharmacol	10.2147/CPAA.S148448	2017
Genetics	29192089	Draft Genome Sequence of Pseudomonas aeruginosa ATCC 9027, Originally Isolated from an Outer Ear Infection.	Jayal A, Johns BE, Purdy KJ, Maddocks SE	Genome Announc	10.1128/genomeA.01397-17	2017		Phylogeny
	29568291	Macroalgae Extracts From Antarctica Have Antimicrobial and Anticancer Potential.	Martins RM, Nedel F, Guimaraes VBS, da Silva AF, Colepicolo P, de Pereira CMP, Lund RG	Front Microbiol	10.3389/fmicb.2018.00412	2018
Pathogenicity	30007709	Experimental approach for a possible integrated protocol to determine sanitizer activity against both planktonic bacteria and related biofilms.	Campana R, Ciandrini E, Baffone W	Food Res Int	10.1016/j.foodres.2018.05.067	2018	Anti-Infective Agents/pharmacology, Biofilms/drug effects, Candida albicans/drug effects, Colony Count, Microbial, Disinfectants/pharmacology, Enterococcus faecalis/drug effects, Escherichia coli O157/drug effects, Plankton/*drug effects, Pseudomonas aeruginosa/drug effects, Stainless Steel, Staphylococcus aureus/drug effects
	30108909	Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.	Consoli GML, Granata G, Picciotto R, Blanco AR, Geraci C, Marino A, Nostro A	Medchemcomm	10.1039/c7md00527j	2017
	30123610	Antimicrobial activities of endophytic fungi of the Sri Lankan aquatic plant Nymphaea nouchali and chaetoglobosin A and C, produced by the endophytic fungus Chaetomium globosum.	Dissanayake RK, Ratnaweera PB, Williams DE, Wijayarathne CD, Wijesundera RLC, Andersen RJ, de Silva ED	Mycology	10.1080/21501203.2015.1136708	2016
Metabolism	30264296	Overproduction of rhamnolipids in Pseudomonas aeruginosa PA14 by redirection of the carbon flux from polyhydroxyalkanoate synthesis and overexpression of the rhlAB-R operon.	Gutierrez-Gomez U, Soto-Aceves MP, Servin-Gonzalez L, Soberon-Chavez G	Biotechnol Lett	10.1007/s10529-018-2610-8	2018	Carbon Cycle/physiology, Glycolipids/analysis/metabolism, Metabolic Engineering/methods, Operon/genetics, Polyhydroxyalkanoates/analysis/metabolism, *Pseudomonas aeruginosa/genetics/metabolism	Biotechnology
	30334871	Bioactive Glass Granules Inhibit Mature Bacterial Biofilms on the Surfaces of Cochlear Implants.	Hoing B, Kirchhoff L, Arnolds J, Hussain T, Buer J, Lang S, Arweiler-Harbeck D, Steinmann J	Otol Neurotol	10.1097/MAO.0000000000002021	2018	Biofilms/growth & development, Cochlear Implants/microbiology, Glass, Prosthesis-Related Infections/prevention & control, Pseudomonas Infections/prevention & control, Pseudomonas aeruginosa, Staphylococcal Infections/prevention & control, Staphylococcus aureus, Staphylococcus epidermidis
Pathogenicity	30392156	N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.	Asadipour A, Moshafi MH, Khosravani L, Moghimi S, Amou E, Firoozpour L, Ilbeigi G, Beiki K, Soleimani E, Foroumadi A	Daru	10.1007/s40199-018-0226-0	2018	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Bacillus subtilis/drug effects, Ciprofloxacin/analogs & derivatives/chemistry, Drug Design, Fluoroquinolones/chemical synthesis/chemistry/pharmacology, Gram-Positive Bacteria/drug effects, Microbial Sensitivity Tests, Molecular Structure, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects, Structure-Activity Relationship
Pathogenicity	30587160	Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study.	Mangiaterra G, Amiri M, Di Cesare A, Pasquaroli S, Manso E, Cirilli N, Citterio B, Vignaroli C, Biavasco F	BMC Infect Dis	10.1186/s12879-018-3612-9	2018	Cystic Fibrosis/complications/microbiology, Female, Humans, Limit of Detection, Lung/microbiology, Male, Microbial Viability, Microbiological Techniques/standards, Pseudomonas Infections/complications/diagnosis/microbiology, Pseudomonas aeruginosa/cytology/genetics/isolation & purification, Real-Time Polymerase Chain Reaction/methods, Reproducibility of Results, Sensitivity and Specificity, Sputum/microbiology	Enzymology
	30719037	Total Phenolic Content and Antioxidant and Antibacterial Activities of Pereskia bleo.	Johari MA, Khong HY	Adv Pharmacol Sci	10.1155/2019/7428593	2019
	30746069	Design, synthesis, and biological activity of novel ammonium salts containing sterically hindered phenolic fragment and phosphoryl group.	Starodubtseva RR, Gibadullina EM, Pazilova NB, Sapunova AS, Voloshina AD, Sudakov IA, Vyshtakalyuk AB, Pudovik MA, Burilov AR, Bukharov SV	Medchemcomm	10.1039/c8md00481a	2018
Pathogenicity	30813368	Chemical Composition and Antimicrobial Activity of Laurus nobilis L. Essential Oils from Bulgaria.	Fidan H, Stefanova G, Kostova I, Stankov S, Damyanova S, Stoyanova A, Zheljazkov VD	Molecules	10.3390/molecules24040804	2019	Anti-Infective Agents/chemistry/pharmacology, Bacteria/drug effects, Bulgaria, Fruit/chemistry, Fungi/drug effects, Laurus/chemistry, Microbial Sensitivity Tests, Oils, Volatile/*chemistry/pharmacology, Plant Leaves/chemistry, Plant Oils/chemistry/pharmacology
Pathogenicity	31078627	Colorimetric microdilution assay: Validation of a standard method for determination of MIC, IC50%, and IC90% of antimicrobial compounds.	Veiga A, Toledo MDGT, Rossa LS, Mengarda M, Stofella NCF, Oliveira LJ, Goncalves AG, Murakami FS	J Microbiol Methods	10.1016/j.mimet.2019.05.003	2019	Anti-Bacterial Agents/pharmacology, Candida albicans/drug effects, Chloramphenicol/pharmacology, Colorimetry/methods, Escherichia coli/drug effects, Ketoconazole/pharmacology, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects
	31136634	Antibacterial activity of lysozyme-chitosan oligosaccharide conjugates (LYZOX) against Pseudomonas aeruginosa, Acinetobacter baumannii and Methicillin-resistant Staphylococcus aureus.	Saito H, Sakakibara Y, Sakata A, Kurashige R, Murakami D, Kageshima H, Saito A, Miyazaki Y	PLoS One	10.1371/journal.pone.0217504	2019	Acinetobacter baumannii/growth & development, Anti-Bacterial Agents/chemistry/pharmacology, Chitosan/chemistry/pharmacology, Methicillin-Resistant Staphylococcus aureus/growth & development, Muramidase/chemistry/pharmacology, Oligosaccharides/chemistry/pharmacology, Pseudomonas aeruginosa/*growth & development
	31217374	Enhanced synergistic effects of xylitol and isothiazolones for inhibition of initial biofilm formation by Pseudomonas aeruginosa ATCC 9027 and Staphylococcus aureus ATCC 6538.	Zhou G, Peng H, Wang YS, Huang XM, Xie XB, Shi QS	J Oral Sci	10.2334/josnusd.18-0102	2019	Anti-Bacterial Agents, Anti-Infective Agents, Biofilms, Pseudomonas aeruginosa, Staphylococcus aureus, Xylitol
Enzymology	31512096	Biological functions of nirS in Pseudomonas aeruginosa ATCC 9027 under aerobic conditions.	Zhou G, Peng H, Wang YS, Li CL, Shen PF, Huang XM, Xie XB, Shi QS	J Ind Microbiol Biotechnol	10.1007/s10295-019-02232-z	2019	Aerobiosis, Biofilms, Gene Expression Regulation, Bacterial, Nitrite Reductases/genetics/metabolism, Pseudomonas aeruginosa/enzymology/genetics, Transcriptome	Transcriptome
Metabolism	31553498	Functional roles of norCB in Pseudomonas aeruginosa ATCC 9027 under aerobic conditions.	Zhou G, Wang YS, Peng H, Shen PF, Xie XB, Shi QS	J Basic Microbiol	10.1002/jobm.201900267	2019	Aerobiosis, Bacterial Proteins/genetics/metabolism, Biofilms/growth & development, Gene Expression Regulation, Bacterial, Gene Knockout Techniques, Hydrogen Peroxide/metabolism, Locomotion/genetics, Oxidoreductases/genetics/metabolism, Pseudomonas aeruginosa/genetics/growth & development/*metabolism, Pyocyanine/biosynthesis	Enzymology
	31581500	Influence of Short Cationic Lipopeptides with Fatty Acids of Different Chain Lengths on Bacterial Biofilms Formed on Polystyrene and Hydrogel Surfaces.	Paduszynska MA, Maciejewska M, Neubauer D, Golacki K, Szymukowicz M, Bauer M, Kamysz W	Pharmaceutics	10.3390/pharmaceutics11100506	2019
Metabolism	31705932	Rapid and solitary production of mono-rhamnolipid biosurfactant and biofilm inhibiting pyocyanin by a taxonomic outlier Pseudomonas aeruginosa strain CR1.	Sood U, Singh DN, Hira P, Lee JK, Kalia VC, Lal R, Shakarad M	J Biotechnol	10.1016/j.jbiotec.2019.11.004	2019	Biofilms/drug effects, Carbon/metabolism, Genome, Bacterial/genetics, Glycolipids/chemistry/metabolism, Pseudomonas aeruginosa/genetics/growth & development/metabolism, Pyocyanine/chemistry/metabolism/pharmacology, Surface-Active Agents/chemistry/metabolism	Genetics
	31835470	Prevention of Pseudomonas aeruginosa Biofilm Formation on Soft Contact Lenses by Allium sativum Fermented Extract (BGE) and Cannabinol Oil Extract (CBD).	Di Onofrio V, Gesuele R, Maione A, Liguori G, Liguori R, Guida M, Nigro R, Galdiero E	Antibiotics (Basel)	10.3390/antibiotics8040258	2019
Pathogenicity	31941794	Antimicrobial Effectiveness in Eye Drops: Limited Sterility versus Reduction in Microbial Count.	Abu Shaqra QM, Al-Groom RM, Abu Shaqra AQ	PDA J Pharm Sci Technol	10.5731/pdajpst.2019.009845	2020	Anti-Infective Agents/administration & dosage/standards, Chemistry, Pharmaceutical/methods/standards, Colony Count, Microbial/standards, Drug Contamination/prevention & control, Humans, Ophthalmic Solutions/administration & dosage/standards, Preservatives, Pharmaceutical/administration & dosage, Pseudomonas aeruginosa/drug effects/physiology, Sterilization/methods/standards
Pathogenicity	32084198	Imaging studies of bacterial biofilms on cochlear implants-Bioactive glass (BAG) inhibits mature biofilm.	Kirchhoff L, Arweiler-Harbeck D, Arnolds J, Hussain T, Hansen S, Bertram R, Buer J, Lang S, Steinmann J, Hoing B	PLoS One	10.1371/journal.pone.0229198	2020	Anti-Bacterial Agents/pharmacology, Bacteria/drug effects/ultrastructure, Bacterial Physiological Phenomena/drug effects, Biofilms/drug effects/growth & development, Cochlear Implants/microbiology, Glass, Microscopy, Electron, Scanning, *Molecular Imaging
Metabolism	32104693	Enhancement of Antibacterial Activity of Paludifilum halophilum and Identification of N-(1-Carboxy-ethyl)-phthalamic Acid as the Main Bioactive Compound.	Frikha-Dammak D, Fakhfakh J, Belhaj D, Bouattour E, Ayadi H, Chaabouni M, Ayadi H, Maalej S	Biomed Res Int	10.1155/2020/4805706	2020	Anti-Bacterial Agents/chemistry/metabolism/pharmacology, Bacillales/metabolism, Pseudomonas aeruginosa/growth & development, Salmonella enterica/growth & development
Pathogenicity	32139293	Synthesis of novel 2, 3, 5-tri-substituted thiazoles with anti-inflammatory and antibacterial effect causing clinical pathogens.	Ahmed A, Molvi KI, Patel HM, Ullah R, Bari A	J Infect Public Health	10.1016/j.jiph.2020.02.002	2020	Animals, Anti-Bacterial Agents/chemical synthesis/pharmacology, Anti-Inflammatory Agents/chemical synthesis/pharmacology, Edema/drug therapy, Female, Fluoroquinolones/chemical synthesis/pharmacology, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Male, Microbial Sensitivity Tests, Rats, Structure-Activity Relationship, Thiazoles/chemical synthesis/*pharmacology
Pathogenicity	32297570	Antimicrobial and Antibiofilm Activity of Lys-[Trp6]hy-a1 Combined with Ciprofloxacin Against Gram-Negative Bacteria.	Carneiro VA, de Oliveira ST, Silva RL, de Sousa Duarte H, Silva ML, Matos MNC, Cavalcante RMB, Figueira CS, Lorenzon EN, Cilli EM, da Cunha RMS	Protein Pept Lett	10.2174/0929866527666200416145549	2020	Anti-Bacterial Agents/chemistry/pharmacology, Biofilms/drug effects/growth & development, Ciprofloxacin/chemistry/pharmacology, Klebsiella pneumoniae/physiology, Pore Forming Cytotoxic Proteins/chemistry/pharmacology, Pseudomonas aeruginosa/physiology
	32378141	Survival strategy of Pseudomonas aeruginosa on the nanopillar topography of dragonfly (Pantala flavescens) wing.	Kamarajan BP, Muthusamy A	AMB Express	10.1186/s13568-020-01021-7	2020
	32691823	The outlier Pseudomonas aeruginosa strain ATCC 9027 harbors a defective LasR quorum-sensing transcriptional regulator.	Garcia-Reyes S, Soto-Aceves MP, Cocotl-Yanez M, Gonzalez-Valdez A, Servin-Gonzalez L, Chavez GS	FEMS Microbiol Lett	10.1093/femsle/fnaa122	2020	Bacterial Proteins/genetics, Mutation, Pseudomonas aeruginosa/genetics/pathogenicity, Quorum Sensing/genetics, Trans-Activators/genetics
	32887236	Activity of Temporin A and Short Lipopeptides Combined with Gentamicin against Biofilm Formed by Staphylococcus aureus and Pseudomonas aeruginosa.	Paduszynska MA, Greber KE, Paduszynski W, Sawicki W, Kamysz W	Antibiotics (Basel)	10.3390/antibiotics9090566	2020
	33235705	Evaluation of antibacterial activity of enterocin A-colicin E1 fusion peptide.	Fathizadeh H, Saffari M, Esmaeili D, Moniri R, Salimian M	Iran J Basic Med Sci	10.22038/ijbms.2020.47826.11004	2020
Pathogenicity	33387272	Biomedical Applications of Mycosynthesized Selenium Nanoparticles Using Penicillium expansum ATTC 36200.	Hashem AH, Khalil AMA, Reyad AM, Salem SS	Biol Trace Elem Res	10.1007/s12011-020-02506-z	2021	Anti-Bacterial Agents/pharmacology, Humans, Metal Nanoparticles, Microbial Sensitivity Tests, Nanoparticles, Penicillium, Selenium/pharmacology, Spectroscopy, Fourier Transform Infrared
Pathogenicity	33450478	Semi-synthesis of N-alkyl-kappa-carrageenan derivatives and evaluation of their antibacterial activity.	Junior EH, Goncalves AG, Noseda MD, Duarte MER, Murakami FS, Ducatti DRB	Carbohydr Res	10.1016/j.carres.2021.108234	2021	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Carbohydrate Conformation, Carrageenan/chemical synthesis/chemistry/pharmacology, Escherichia coli/drug effects, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/*drug effects
	33569376	Comparative Study of the Antimicrobial Activity of Selenium Nanoparticles With Different Surface Chemistry and Structure.	Filipovic N, Usjak D, Milenkovic MT, Zheng K, Liverani L, Boccaccini AR, Stevanovic MM	Front Bioeng Biotechnol	10.3389/fbioe.2020.624621	2021
	33716248	Impact of Spreading Time to Recovery Rate in Suitability Test of Solid Agar Media.	Teramura H, Yasuda E, Naisei Y	Biocontrol Sci	10.4265/bio.26.43	2021	Agar, Aspergillus, Bacillus subtilis, Candida albicans, Escherichia coli, Microbial Sensitivity Tests, Pharmaceutical Preparations
	33917755	In Vitro and In Vivo Evaluation of Silver Nanoparticles Phytosynthesized Using Raphanus sativus L. Waste Extracts.	Ungureanu C, Fierascu I, Fierascu RC, Costea T, Avramescu SM, Calinescu MF, Somoghi R, Pirvu C	Materials (Basel)	10.3390/ma14081845	2021
Pathogenicity	34173930	Anti-Pseudomonas aeruginosa biofilm activity of tellurium nanorods biosynthesized by cell lysate of Haloferax alexandrinus GUSF-1(KF796625).	Alvares JJ, Furtado IJ	Biometals	10.1007/s10534-021-00323-y	2021	Anti-Bacterial Agents/pharmacology, Biofilms, Haloferax, Humans, Nanotubes, *Pseudomonas Infections, Pseudomonas aeruginosa, Tellurium/pharmacology
Pathogenicity	34235929	Rational Design of Dipicolylamine-Containing Carbazole Amphiphiles Combined with Zn(2+) as Potent Broad-Spectrum Antibacterial Agents with a Membrane-Disruptive Mechanism.	Liu J, Li H, Li H, Fang S, Shi J, Chen Y, Zhong R, Liu S, Lin S	J Med Chem	10.1021/acs.jmedchem.1c00858	2021	Amines/chemistry/pharmacology, Animals, Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Carbazoles/chemistry/pharmacology, Coordination Complexes/chemical synthesis/chemistry/pharmacology, Dose-Response Relationship, Drug, Drug Design, Female, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Keratitis/drug therapy, Mice, Mice, Inbred C57BL, Microbial Sensitivity Tests, Molecular Structure, Picolinic Acids/chemistry/pharmacology, Structure-Activity Relationship, Zinc/chemistry/*pharmacology
	34335776	Determination of the Chemical Composition and Antimicrobial Activity of Lavatera thuringiaca L. Medicinal Herb Material Extracted under Subcritical Conditions by the Liquid Carbon Dioxide Method.	Zhandabayeva MA, Kozhanova KK, Boshkayeva AK, Kataev VA, Ustenova GO, Gemejiyeva NG, Iskakbayeva ZA	Int J Biomater	10.1155/2021/7541555	2021
	34358044	The Autofluorescence Patterns of Acanthamoeba castellanii, Pseudomonas aeruginosa and Staphylococcus aureus: Effects of Antibiotics and Tetracaine.	Peguda HK, Mahbub SB, Sherpa TD, Subedi D, Habibalahi A, Anwer AG, Gu Z, Willcox MDP, Goldys EM, Carnt NA	Pathogens	10.3390/pathogens10070894	2021
Metabolism	34418194	PqsR-independent quorum-sensing response of Pseudomonas aeruginosa ATCC 9027 outlier-strain reveals new insights on the PqsE effect on RhlR activity.	Garcia-Reyes S, Cocotl-Yanez M, Soto-Aceves MP, Gonzalez-Valdez A, Servin-Gonzalez L, Soberon-Chavez G	Mol Microbiol	10.1111/mmi.14797	2021	Bacterial Proteins/genetics/metabolism, Frameshift Mutation, Gene Expression Regulation, Bacterial, Glycolipids/metabolism, Humans, Mutation, Operon, Pseudomonas Infections/microbiology, Pseudomonas aeruginosa/genetics/metabolism, Pyocyanine/biosynthesis, Quinolones/metabolism, Quorum Sensing, Regulon, Thiolester Hydrolases/genetics/*metabolism, Trans-Activators, Virulence Factors/genetics/metabolism	Pathogenicity
	34424157	Vfr or CyaB promote the expression of the pore-forming toxin exlBA operon in Pseudomonas aeruginosa ATCC 9027 without increasing its virulence in mice.	Garcia-Reyes S, Moustafa DA, Attree I, Goldberg JB, Quiroz-Morales SE, Soberon-Chavez G	Microbiology (Reading)	10.1099/mic.0.001083	2021	Animals, Bacterial Proteins/genetics, Mice, Operon, Pseudomonas aeruginosa/genetics, Quorum Sensing, Virulence/genetics, Virulence Factors/genetics
Phylogeny	34577029	Biosynthesis of Selenium Nanoparticles (via Bacillus subtilis BSN313), and Their Isolation, Characterization, and Bioactivities.	Ullah A, Yin X, Wang F, Xu B, Mirani ZA, Xu B, Chan MWH, Ali A, Usman M, Ali N, Naveed M	Molecules	10.3390/molecules26185559	2021	Antioxidants, Bacillus subtilis, Dietary Supplements, Nanoparticles, Particle Size, *Selenium
	34598437	Behavior of Pseudomonas aeruginosa strains on the nanopillar topography of dragonfly (Pantala flavescens) wing under flow conditions.	Kamarajan BP, Ananthasubramanian M, Sriramajayam L, Boppe A	Biointerphases	10.1116/6.0001303	2021	Animals, Anti-Bacterial Agents, Hemiptera, Odonata, Pseudomonas aeruginosa, Wings, Animal
	34827238	Essential Oil and Hydrophilic Antibiotic Co-Encapsulation in Multiple Lipid Nanoparticles: Proof of Concept and In Vitro Activity against Pseudomonas aeruginosa.	Ben-Khalifa R, Gaspar FB, Pereira C, Chekir-Ghedira L, Rodriguez-Rojo S	Antibiotics (Basel)	10.3390/antibiotics10111300	2021
	34827325	Chemical Profile of the Volatile Constituents and Antimicrobial Activity of the Essential Oils from Croton adipatus, Croton thurifer, and Croton collinus.	Cucho-Medrano JLL, Mendoza-Beingolea SW, Fuertes-Ruiton CM, Salazar-Salvatierra ME, Herrera-Calderon O	Antibiotics (Basel)	10.3390/antibiotics10111387	2021
	34900433	Removal of heavy oil from contaminated surfaces with a detergent formulation containing biosurfactants produced by Pseudomonas spp.	Farias CBB, Soares da Silva RCF, Almeida FCG, Santos VA, Sarubbo LA	PeerJ	10.7717/peerj.12518	2021
	35298856	Antimicrobial potential of natural deep eutectic solvents.	Al-Akayleh F, Khalid RM, Hawash D, Al-Kaissi E, Al-Adham ISI, Al-Muhtaseb N, Jaber N, Al-Remawi M, Collier PJ	Lett Appl Microbiol	10.1111/lam.13699	2022
Cultivation	35315693	GVPC Medium Manufactured without Oxygen Improves the Growth of Legionella spp. and Exhibits Enhanced Selectivity Properties.	Casino P, Lopez A, Peiro S, Rios M, Rios S, Porta A, Agusti G, Asensio D, Marques AM, Pique N	Microbiol Spectr	10.1128/spectrum.02401-21	2022	Culture Media, Cycloheximide, Escherichia coli, Glycine, Legionella, Legionella pneumophila, Oxygen, Polymyxins, Vancomycin, Water, Water Microbiology
	35912375	Component Composition and Biological Activity of Various Extracts of Onosma gmelinii (Boraginaceae).	Shilov SV, Ustenova GO, Kiyekbayeva LN, Korotetskiy IS, Kudashkina NV, Zubenko NV, Parenova RA, Jumagaziyeva AB, Iskakbayeva ZA, Kenesheva ST	Int J Biomater	10.1155/2022/4427804	2022
	36006860	Phytochemical Analysis and Antibacterial Activity of Achillea coarctata Poir. Essential Oils.	Stamenkovic JG, Petrovic GM, Dordevic AS	Chem Biodivers	10.1002/cbdv.202200578	2022	Oils, Volatile/chemistry, Achillea/chemistry, Eucalyptol, Staphylococcus aureus, Microbial Sensitivity Tests, Gas Chromatography-Mass Spectrometry, Anti-Bacterial Agents/chemistry, Plant Oils/chemistry, Terpenes/chemistry, Phytochemicals
Phylogeny	36050590	Larval gut microbiome of Pelidnota luridipes (Coleoptera: Scarabaeidae): high bacterial diversity, different metabolic profiles on gut chambers and species with probiotic potential.	Falqueto SA, de Sousa JR, da Silva RC, da Silva GF, Pinheiro DG, Soares MA	World J Microbiol Biotechnol	10.1007/s11274-022-03387-1	2022	Animals, Bacteria, Coleoptera, Fungi/genetics, Gastrointestinal Microbiome, Larva/microbiology, Metabolome, *Probiotics, RNA, Ribosomal, 16S
Pathogenicity	36088756	Design, synthesis, and biological evaluation of tetrahydroquinoline amphiphiles as membrane-targeting antimicrobials against pathogenic bacteria and fungi.	Liu J, Li H, He Q, Chen K, Chen Y, Zhong R, Li H, Fang S, Liu S, Lin S	Eur J Med Chem	10.1016/j.ejmech.2022.114734	2022	Humans, Mice, Animals, Gram-Negative Bacteria, Gram-Positive Bacteria, Anti-Bacterial Agents/chemistry, Microbial Sensitivity Tests, Anti-Infective Agents, Bacteria, Fungi
	36233025	A Multidisciplinary Approach in Examining the Susceptibility to Microbial Attack of Polyacrylic and Polyurethane Resins Used in Art Restoration.	Campana R, Sabatini L, Giorgi L, Pettinari G, Valentini L, Gobbi P	Int J Mol Sci	10.3390/ijms231911725	2022	Bacteria, Disinfectants, Esters, Fungi, Penicillium, Polymers, Polyurethanes/pharmacology
	36421304	Defining Exposure Predictors of Meropenem That Are Associated with Improved Survival for Severe Bacterial Infection: A Preclinical PK/PD Study in Sepsis Rat Model.	Wang Y, Liu L, Wu Q, Yin Q, Xie F	Antibiotics (Basel)	10.3390/antibiotics11111660	2022

Reference

@id	authors	catalogue	doi/url	title	journal	pubmed
572	Curators of the DSMZ	Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 1128)	https://www.dsmz.de/collection/catalogue/details/culture/DSM-1128
20215	Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.		10.1099/ijsem.0.004332	List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218	Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.		10.1016/j.syapm.2013.11.002	StrainInfo introduces electronic passports for microorganisms.	Syst Appl Microbiol. 37: 42-50 2014	24321274
41819	Curators of the CIP		https://brclims.pasteur.fr/brcWeb/souche/detail/1/11396
47686	Curators of the CCUG	Culture Collection University of Gothenburg (CCUG) (CCUG 22801)	https://www.ccug.se/strain?id=22801
66792	Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann		https://diaspora-project.de/progress.html#genomes	Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
67770	Curators of the JCM		https://jcm.brc.riken.jp/en/
68369				Automatically annotated from API 20NE
68382				Automatically annotated from API zym
69480	Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann		https://diaspora-project.de/progress.html#genomes	Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
69481	Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch		10.21203/rs.3.rs-2527258/v1	Predictions based on the model GenomeNet Sporulation v. 1
81969	Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.		10.60712/SI-ID3893.1	StrainInfo: A central database for resolving microbial strain identifiers
116095	Curators of the CIP	Collection of Institut Pasteur (CIP 82.118)	https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2082.118